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ABSTRACT 
All animals live in symbiosis. Shaped by eons of co-evolution, host-bacterial 
associations have developed into prosperous relationships creating mechanisms for 
mutual benefits to both microbe and host. No better example exists in biology than the 
astounding numbers of bacteria harbored by the lower gastrointestinal tract of mammals. 
This community of symbionts establishes a life-long habitat within the distal gut and 
profoundly impacts host health.  Although many recent investigations have led to 
determination of the microbiota composition, molecular mechanisms mediating 
establishment and maintenance of the microbial community within the gut is poorly 
described.  
We use gnotobiotic mice to elucidate mechanisms of colonization by Bacteroides, 
one of the most numerically prominent genera in the intestine.  We generate mutant 
strains of Bacteroides fragilis that lack the ability to express multiple capsular 
polysaccharides and demonstrate defect in colonization in competition with wild-type 
strain, suggesting a role for surface sugar architecture during host-symbiont mutualism.  
Through a functional in vivo genetic screen of colonization, we identify a novel operon 
from the genome of B. fragilis that is highly conserved among many sequenced intestinal 
Bacteroides and that mediate a species-specific colonization profile.  We have named this 
genetic locus the commensal colonization factor (ccf).  B. fragilis deleted in the ccf genes 
exhibit colonization defects in both germ-free and complex microbiota harboring mice. 
The ccf genes of B. fragilis are up-regulated during gut colonization, preferentially at the 
mucosal surface, supporting an in vivo function. Indeed, deletion of ccf genes leads to 
reduced mucosal association and a defect in bacterial occupation of colonic crypts of 
  vii 
mice.  The ability of B. fragilis to repopulate the gut after antibiotic perturbation or 
gastroenteritis requires expression of ccf, suggesting the niche within colonic crypts 
represents a colonization reservoir for the gut microbiota following environmental stress.  
These findings suggest a novel and evolutionarily conserved mechanism for persistent 
gut colonization by the Bacteroides species.   
 
  viii 
TABLE OF CONTENTS 
 
Acknowledgements…………………...……………………………………………….…iii 
Abstract………………………………..………………………………………………….vi 
Table of Contents……………..………...…………………………………………….…viii 
Chapter 1: 
Introduction……...…………………………………………………………….…………..1 
Chapter 2: 
Regulation of surface architecture by symbiotic bacteria mediates host 
colonization…………………………………………………………………..…………..16 
Chapter 3: 
Commensal colonization factors promote specificity and stability of the gut microbiome 
……...………………………………………………………………………………..…...55 
Chapter 4: 
Conclusions and future directions……………………………………………………....101 
Appendix I: 
The human commensal Bacteroides fragilis binds intestinal mucin………………...…108 
Appendix II: 
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human 
microbiota………………………………………………………………………………114 
 
  1 
 
 
 
Chapter 1: 
 
Introduction 
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1. The human gut microbiota  
Immediately upon a sterile birth, mammals are coordinately colonized with 
complex communities of bacteria on all environmentally exposed surfaces (Ley et al., 
2006).   After weaning, a compositionally stable and numerically vast microbial 
ecosystem is formed in the gastrointestinal tract (Palmer et al., 2007). During adulthood, 
the human gut harbors up to 100 trillion (1014) microbes. This is equivalent to 1011-1012 
cells/g colonic content with a biomass of >1 kg, which is the highest density recorded for 
any microbial habitat (O’Hara et al., 2006; Whitman et al., 1998). Our knowledge of the 
composition of the human gut microbiota was limited to culture-based studies until recent 
initiatives utilizing high-throughput sequencing of bacterial 16S rRNA genes made 
available a detailed inventories of the normal human gut microbiome comparing 
individuals and populations across different age groups and geographic regions (The 
Human Microbiome Project Consortium, 2012; Yatsunenko et al., 2012; Eckburg et al., 
2005; Zoetendal et al., 2002; Xu et al., 2007). Such comprehensive sequence-based 
microbiome profiling studies not only increased our understanding of the population 
composition, dynamics and ecology of the gut microbiota but gave us evolutionary 
insight into the host-microbe mutualism. Although there are at least 55 divisions of 
Bacteria and 13 different divisions of Archaea on Earth, the human distal gut microbial 
community is dominated by members of just two bacterial divisions, Bacteroidetes and 
Firmicutes, and one member of Archaea, Methanobrevibacter smithii (Eckburg et al., 
2005). In contrast to the low levels of deep diversity, the microbial diversity in 
mammalian gut exhibits high levels of variation at the level of species and strains.  Such 
extreme fan-like phylogenetic architecture is unique to the mammalian gut microbiota 
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and may reflect a long history of co-evolution between microbes and their hosts whereby 
a few early successful colonizers have maintained an exclusive membership within the 
gut and have undergone diversification into species and strains (Backhed et al., 2005; 
Dethlefsen et al., 2007; Ley et al., 2006). 
The gut ecosystem is dynamic. Within a given intestinal habitat, some microbial 
members may be bona fide “residents” (autochthonous components) that have established 
commensal status in the gut and persist throughout the lifetime of the host.   However, 
detection of a particular bacterial species from the fecal bacterial community does not 
necessarily mean that the bacteria are permanent inhabitants of the gut ecosystem.  Some 
microbes found in the gut can be described more accurately as “transient” components 
(allochthonous members) of the gut microbial communities which originate from 
ingested food, water and various components of our environment.  The difference 
between the mucosa-associated bacterial communities in the colon and the luminal and 
fecal bacterial communities can be attributed in part to the different nature of the 
microbial inhabitance found in different niches within the gut at a given time (Zoetendal 
et al., 2002).  In order to fully understand the human biology with respect to the human 
microbiota, it is crucial to determine which compartment of the microbiota is genuinely 
autochthonous to the human gut and discover the molecular traits that enable the resident 
bacterial species to establish and maintain colonization in a highly variable and 
competitive environment.     
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2. Study of host-bacterial mutualism using gnotobiology 
  Gut microbiota sequencing efforts led us to obtain insights into the ecological and 
evolutionary pressures shaping the community structure. However, snap-shot profiling 
approach alone cannot address questions regarding specific requirements for a given 
microbial species to be recognized by the host as a commensal organism and be tolerated. 
One of the most successful experimental approaches to dissect the intricate crosstalk 
between host and commensal bacteria can be found in the use of gnotobiotic animal 
models. Traditionally performed with rodents, the presence and composition of the 
microbiota is experimentally manipulated using germ-free host animals. Comparative 
studies of germ-free and conventionally colonized animals have demonstrated the 
profound impact of the gut microbiota on the host biology ranging from the mucosal and 
systemic immunity and morphological integrity of the intestinal epithelial cells to the 
metabolic, absorptive and endocrine functions (Round and Mazmanian, 2009; Smith et 
al., 2007). Experiments comparing the gene expression profiles of the intestinal epithelial 
layer between colonized and germ-free animals have shown direct host response to 
intestinal bacteria at the molecular level (Backhed et al., 2004; Hooper et al., 2003; 
Hooper et al., 2001; Salzman et al., 2007; Stappenbeck et al., 2002). Germ-free animals 
mono-associated with a single microbial species or purified microbial compounds 
provided a powerful tool for dissecting which microbial signals are required for 
mutualistic interaction with the host (Bry et al., 1996; Hooper et al., 1999; Mazmanian et 
al., 2005; Freitas et al., 2005).   
  One of the pioneering works by McFall-Ngai and colleagues discovered a 
“mutualism factor” from an elegant model of host-bacterial symbiosis between the 
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marine bacterium Vibrio fischeri and its squid host Euprymna scolopes (Nyholm and 
McFall-Ngai, 2003; Nyholm and McFall-Ngai, 2004). In this partnership, the squid 
provides a nutrient-rich environment for its luminescent symbiont in a specialized light 
organ. Upon bacterial colonization, the squid undergoes a dramatic morphogenesis which 
is associated with symbiosis. Interestingly, much of the host morphogenetic program can 
be induced by conserved components of bacterial cell walls, lipopolysaccharide (LPS) 
and peptidoglycan (PGN) (Koropatnick et al., 2004). This is an example of host-
microbial mutualism driven by microbial factors which are none other than ligands of 
innate immune system called pattern recognition receptors (PRRs), also known as 
microbial-associated molecular patterns (MAMPs).  Although MAMPs are commonly 
linked with pathogenesis in animals, it appears that microbes can use similar molecular 
signals to mediate beneficial interaction with the host in a context-dependent manner 
(Cheesman and Guillemin, 2007). In summary, gnotobiotic experimental strategies have 
been instrumental for identifying some of the key molecular mechanisms underlying 
mutualism between host and microbes.     
 
3. The Bacteroides as important members of the microbiota  
Bacteroidetes comprises one of the most numerically abundant Gram-negative 
phyla in the mammalian gastrointestinal tract GI (Palmer et al., 2007; Ley et al., 2008). 
One of the first evidences of gut microbiota playing an active role in the host biology was 
demonstrated by mono-association of germ-free mice with Bacteroides thetaiotaomicron 
which then induced carbohydrate decorations of the intestinal epithelium to mediate the 
normal architectural development of host tissue (Bry et al., 1996). DNA microarray 
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profiling of the global host transcriptional responses in germ-free mice mono-associated 
with B. thetaiotaomicron revealed a number of genes involved with regulation of 
postnatal maturation (adenosine deaminase), nutrient uptake and metabolism (SGLT-1, 
colipase, L-FABP), processing of angiogenesis (angiogenin-3) and fortification of the 
host epithelial barrier (DAF, CRP-ductin, Sprr2a) (Hooper et al., 2001). These studies 
demonstrated a remarkable example of a single species of commensal organism restoring 
many of the structural, metabolic and developmental defects of a previously germ-free 
host. B. thetaiotaomicron has also been shown to induce the production of anti-microbial 
immune defenses during colonization, to protect their host from invading pathogens 
(Cash et al., 2006). Bacteroides fragilis is a gut commensal that aids in host health by 
directing the cellular and physical maturation of the developing immune system of the 
host (Mazmanian et al., 2005) and by protecting animals from inflammatory disease such 
as colitis and multiple sclerosis (Mazmanian et al., 2008; Lee et al., 2011; Ochoa-Reparaz 
et al., 2010). B. fragilis produces an immunomodulatory molecule that can reprogram the 
host immune system to produce anti-inflammatory molecules required for protection 
from disease in animals (Round and Mazmanian, 2010). In summary, many Bacteroides 
species have been well documented for their beneficial interactions with the host and 
emerged as model organisms for the study of host-bacterial mutualism.  
 
4. Mucosal surface colonization by commensal bacteria 
Host-microbe interactions often begin with colonization of the mucosal surfaces. 
Understanding the host-microbe interaction at the mucosal surface is fundamental to 
uncovering colonization mechanism of commensal bacteria in the gut. However, studying 
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the interactions between host and bacteria through the thickness of the mucus layer in 
vivo is a technically formidable task.  Our current understanding of how certain bacteria 
interact with mucus layer is mainly limited to in vitro bacterial mucin-binding studies 
which may not recapitulate inside the host intestinal tract.   
The mucus gel layer of the large intestine is a dense matrix of polysaccharides 
(and proteins) derived mainly from the epithelium’s goblet cell lineage. Its thickness and 
mucin composition vary along the length of the gut (Matsuo et al., 1997). Traditionally, 
the mucus gel layer is considered a buffer between the highly immunogenic luminal 
content (commensals and pathogens alike) and the host epithelial layer to protect both the 
host and the gut bacteria (Deplancke and Gaskins, 2001). On the contrary, the mucus 
layer can represent a habitat and source of nutrients for the bacterial communities that 
colonize mucosal surfaces (Sonnenburg et al., 2004). The ability of mucus to support the 
growth of bacteria is evident from numerous in vitro studies in which bacteria have been 
shown to grow readily in mucus preparations (Jonsson et al., 2001; McCormick et al., 
1988). Using streptomycin-treated mouse model, several mucus-derived sugars were 
described as major carbon sources required for E. coli colonization of the gut (Chang et 
al., 2004).  Initially, a whole-genome transcriptional profiling of E. coli strain MG1655 
during growth ex vivo on cecal mucus was conducted.  Several nutritional genes 
corresponding to catabolic pathways for nutrients found in mucus were induced.  Each 
pathway was systematically knocked out and the mutants were tested for fitness in mouse 
intestine colonization.  Competitive colonization between wild-type MG1655 and 
isogenic mutants that lack the ability to catabolize various nutrients confirmed that 
carbohydrate catabolism plays a dominant role in the initiation and maintenance of E. coli 
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colonization of the mouse intestine (Chang et al., 2004).  Nutrient availability within the 
colon mucus layer creates an attractive ecological niche for bacteria and thus provides at 
least one likely mechanism of gut colonization by commensal bacteria.  
Analysis of carbohydrate structures along the length of the gastrointestinal tract of 
two humans showed that although their mucin-associated glycans were diverse, their 
region-specific glycosylation patterns were well conserved (Robbe et al., 2003).  These 
glycoproteins and mucoproteins on the mucosal surface of the host gut can serve as 
receptor sites for attachment and adherence by commensal bacteria (Baranov and 
Hammarstrom, 2004; Granato et al., 2004). High diversity among the glycans with 
conserved spatial patterns found on the gut mucosal surface strongly suggests a 
mechanism of host-driven (maybe as a result of bacteria modulating the host) regulation 
of gut microbial community composition by directing members of the microbiota to 
distinct host niches. Host-derived glycan substrates that serve as nutrient source or 
docking sites for specific microbes may describe a mechanism for establishment and 
maintenance of a spatially diversified gut microbiota.  
 
5. The role of bacterial surface structures during colonization 
The microbial envelope represents a functional organelle decorated with 
molecules that provide critical interactions between microorganisms and their 
environment. In addition to proteins, bacterial surfaces are covered with abundant 
amounts of lipopolysaccharides, exopolysaccharides and capsular polysaccharides. 
Capsule production has been shown to be required for bacterial virulence by numerous 
pathogens, and polysaccharides are the key components of many vaccines developed to 
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prevent bacterial infections (Johri et al., 2006; Lee et al., 2001). Conversely, the biologic 
significance of capsular polysaccharide production during beneficial host-bacterial 
commensalism has only recently been investigated (Comstock and Kasper, 2006). Unlike 
pathogens that usually possess few capsular polysaccharides (0–2 per strain), analysis of 
the genomes of all sequenced intestinal Bacteroides species reveal a unique feature: the 
presence of numerous genomic loci that encode for capsular polysaccharides (8–13 per 
strain) (Coyne and Comstock, 2008). It is believed that the multiple capsular 
polysaccharides (and perhaps other surface structures) of Bacteroides create systems for 
altering the physical properties of bacterial surfaces (Xu et al., 2007). Several reports 
have predicted that the expression of multiple capsular polysaccharides by B. fragilis 
provide functions that are critical for host-bacterial symbiosis (Krinos et al., 2001; 
Kuwahara et al., 2004; Cerdeno-Tarraga et al., 2005). It appears that Bacteroides have 
invested heavily in the development of dynamic molecular mechanisms to establish 
residence within the mammalian ecosystem.  
There are many examples of adherence mechanisms employed by bacterial 
pathogens during infection; including molecules such as pili, fimbriae, surface proteins, 
teichoic acids, lipopolysaccharides and other carbohydrates (Pizarro-Cerda and Cossart, 
2006). Unlike pathogens which generally cause acute infections, symbiotic bacteria have 
evolved to associate with their hosts for prolonged periods of time. However, 
mechanisms involved in sustained colonization by beneficial bacteria remain largely 
undescribed. The following chapters in this thesis describe studies seeking to identify and 
characterize the ‘colonization factors’ of the important human symbiont, B. fragilis. 
Though very speculative, knowing how beneficial bacteria maintain long-term 
  10 
association with their mammalian hosts may provide means to ‘engineer’ delivery of 
health-promoting bacteria as therapeutics for various human diseases.  
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ABSTRACT 
Microbes occupy countless ecological niches in nature. Sometimes these 
environments may be on or within another organism, as is the case in both microbial 
infections and symbiosis of mammals. Unlike pathogens that establish opportunistic 
infections, hundreds of human commensal bacterial species establish a life-long 
cohabitation with their hosts. Although many virulence factors of infectious bacteria have 
been described, the molecular mechanisms used during beneficial host–symbiont 
colonization remain almost entirely unknown. The novel identification of multiple 
surface polysaccharides in the important human symbiont Bacteroides fragilis raised the 
critical question of how these molecules contribute to commensalism. To understand the 
function of the bacterial capsule during symbiotic colonization of mammals, we 
generated B. fragilis strains deleted in the global regulator of polysaccharide expression 
and isolated mutants with defects in capsule expression. Surprisingly, attempts to 
completely eliminate capsule production are not tolerated by the microorganism, which 
displays growth deficits and subsequent reversion to express capsular polysaccharides. 
We identify an alternative pathway by which B. fragilis is able to reestablish capsule 
production and modulate expression of surface structures. Most importantly, mutants 
expressing single, defined surface polysaccharides are defective for intestinal 
colonization compared with bacteria expressing a complete polysaccharide repertoire. 
Restoring the expression of multiple capsular polysaccharides rescues the inability of 
mutants to compete for commensalism. These findings suggest a model whereby display 
of multiple capsular polysaccharides provides essential functions for bacterial 
colonization during host–symbiont mutualism. 
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INTRODUCTION 
We live in a microbial world. Immediately upon birth, humans coordinately 
assemble a complex bacterial microbiota on almost all environmentally exposed surfaces 
(Ley et al., 2006). Although it has been appreciated for decades that humans harbor 
multitudes of commensal bacteria, recent studies have begun to reveal the extraordinary 
diversity and complexity of the ecosystem we provide to microorganisms. Advances in 
genomic technologies have demonstrated that we harbor dozens of bacterial species in 
our stomachs, hundreds on our skin and oral cavity, and thousands within our lower 
gastrointestinal tract (Bik et al., 2006; Gao et al., 2007; Gill et al., 2006). The magnitude 
of these interactions and the evolutionary forces that drive them must exert profound 
influences on the biology of both microbe and man. The gastrointestinal tract provides an 
excellent example of the complex interactions between the microbiota and the host 
(Hooper and Gordon, 2001). Bacteria dominate this biological niche, both numerically 
and in terms of diversity. Of the multitudes of bacterial species that colonize the 
mammalian gastrointestinal tract (> 1013 organisms from > 1,000 different species), those 
of the genus Bacteroides are among the most numerically prominent in humans (Eckburg 
et al., 2005). For decades, bacteria have been known to perform the essential function of 
metabolizing complex carbohydrates subsequently used by their mammalian hosts; 
Bacteroides species have been shown to be essential for this function (Hooper et al., 
2002; Xu et al., 2003). Analysis of the genome sequences of the human Bacteroides 
(Bacteroides thetaiotaomicron, Bacteroides vulgatus, Bacteroides distasonis, and 
Bacteroides fragilis) reveals that this genus has evolved numerous glycosidases for 
carbohydrate degradation (Xu et al., 2007). B. thetaiotaomicron induces carbohydrate 
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decorations of the intestinal epithelium to mediate the normal architectural development 
of host tissue (Bry et al., 1996). Furthermore, B. fragilis was first described to produce 
multiple surface capsular polysaccharides (Krinos et al., 2001). It has been recently 
revealed that all studied Bacteroides contain numerous genomic loci for capsular 
polysaccharide production, a unique and distinguishing feature of this genus of bacteria. 
Studies show that various Bacteroides species share with their human host a mammalian-
evolved biochemical pathway for the addition of sugar modifications to surface proteins 
and polysaccharides (Coyne et al., 2005). Moreover, we have recently demonstrated that 
B. fragilis elaborates an important immunomodulatory polysaccharide that instructs the 
normal development of the host immune system (Mazmanian et al., 2005). Thus, the 
Bacteroides have dedicated a significant proportion of their biology to the production and 
functions of capsular polysaccharides during coevolution with mammals.  
Decades of research have assigned various functions to surface polysaccharides of 
pathogens, including biofilm production, tissue adherence, and antiphagocytic activity 
during immune evasion (Mazmanian and Kasper, 2006). Capsule production has been 
shown to be required for bacterial virulence in numerous animal models of disease, and 
polysaccharides are the key components of many vaccines developed to prevent 
pathogenic bacterial infections (Johri et al., 2006; Lee et al., 2001). Conversely, the 
biologic significance of capsular polysaccharide production during beneficial host–
bacterial commensalism has only recently been suggested (Comstock and Kasper, 2006). 
It is believed that the multiple capsular polysaccharides (and perhaps other surface 
structures) of the Bacteroides create systems for altering the physical properties of 
bacterial surfaces (Xu et al., 2007). Several reports have predicted that the expression of 
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multiple capsular polysaccharides by B. fragilis provides functions that are critical for 
host–bacterial symbiosis (Krinos et al., 2001; Kuwahara et al., 2004; Cerdeno-Tarraga et 
al., 2005). However, this notion currently remains without experimental corroboration. In 
the report contained herein, we examine the role of capsular polysaccharide production 
during the relationship between B. fragilis and its mammalian host. By generating 
bacterial mutants in the regulation of capsule expression, we find that production of at 
least one capsular polysaccharide is required for the viability of the microorganism. Most 
importantly, inhibiting the ability of B. fragilis to modulate its surface architecture 
renders it unable to compete for colonization of the gastrointestinal tract of animals. It 
appears that Bacteroides have invested heavily in the development of dynamic molecular 
mechanisms to establish and maintain residence within the mammalian ecosystem. These 
results provide the foundation for understanding our evolutionary cohabitation with the 
microbial world around and within us. 
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RESULTS 
Capsular polysaccharide expression is critical for B. fragilis. 
The eight known capsular polysaccharide (CPS) biosynthesis loci of B. fragilis 
are scattered throughout the genome as distinct polycistronic operons of 11–22 genes 
(PSA–PSH) (Kuwahara et al., 2004; Coyne et al., 2003). Mpi (multiple promoter 
invertase), a member of the serine site-specific DNA recombinase family, acts as a global 
transcriptional regulator of polysaccharide expression through inverting promoters 
between the ‘‘on’’ and ‘‘off’’ orientations (Figure 2.1A) (Coyne et al., 2003). We 
introduced a genomic mutation in the mpi gene by homologous recombination in a PSA 
deletion background, because PSA is the most abundantly expressed polysaccharide 
[produced by 79% of all bacterial cells in culture (Krinos et al., 2001)]. We subsequently 
screened mutants by PCR using promoter-specific primers to isolate clones with all Mpi-
regulated promoters in the ‘‘locked-off’’ orientation. Similar to previous findings (Coyne 
et al., 2003), cultures of wild-type B. fragilis are heterogeneous with regard to 
polysaccharide expression and are in phase variation displaying both ‘‘on’’ and ‘‘off’’ 
promoters (Figure 2.1B and Supplementary Table 2.1). Upon mutagenesis, we isolated 
one mutant [B. fragilis CPM1 (capsular polysaccharide mutant)] with seven of the eight 
characterized promoters in the ‘‘off’’ orientation at the time of mpi deletion (PSC is not 
controlled by Mpi). When mpi was introduced into CPM1 by transcomplementation, each 
of the Mpi-controlled polysaccharide promoters regained the ability to invert (Figure 
2.1B). We phenotypically verified the presence or absence of CPS synthesis with 
immunoblot analysis using antisera specific for each molecule. A complete loss of 
polysaccharide expression from all Mpi-controlled loci was observed in strain CPM1 
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compared with wild-type B. fragilis (Figure 2.1C). 
                        
Figure 2.1 | Deletion of the global regulator of polysaccharide promoter inversion in B. 
fragilis. (A) Schematic representing promoters flanked by inverted repeats (IR) of polysaccharide 
biosynthesis loci. Mpi induces recombination at the IR sites to invert promoters. Boxes below 
represent PCR products distinguishing “on” and “off” orientations. (B) PCR products generated 
from chromosomal DNA of wild-type B. fragilis 9343, an isolated Δmpi mutant (CPM1), and 
CPM1 strain complemented with the mpi gene (CPM1 pFD340-mpi). Unlike wild-type, all Mpi-
controlled capsular polysaccharide (CPS) promoters are locked “off” in CPM1. Genetic rescue of 
mpi restores phase variation in CPM1. (C) Immunoblot analysis demonstrates that expression of 
PSC is not controlled by Mpi.  Note the absence of all Mpi-regulated CPS and the overexpression 
of PSC. (D) Flow cytometry analysis of surface CPS demonstrates that all CPM1 cells express 
PSC (99.8%) compared to 4.2% in wild-type cultured cells. Black histograms represent the 
control antibody; gray histograms (α-PSC) show PSC on the surface of B. fragilis CPM1.  
 
Expression of the remaining known capsular polysaccharide (PSC) in B. fragilis is 
predicted to not be controlled by promoter inversion, although it shares other critical 
transcriptional regulatory elements with the seven Mpi-regulated CPS (Krinos et al., 
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2001). Indeed, immunoblot analysis showed an increase in PSC production for CPM1 
over that for wild- type cultures (Figure 2.1C). Consistent with this observation, PSC was 
expressed in 100% of cells for the Mpi mutant strain CPM1 but in only 4.2% of wild-type 
cultures when measured by flow cytometry with PSC-specific antiserum (Figure 2.1D). 
Thus, expression of PSC appears to represent a default mechanism for capsule expression 
in the absence of Mpi-regulated polysaccharides. 
 
Capsule mutants spontaneously revert to express capsular polysaccharides. 
To characterize the role of polysaccharide production in B. fragilis, we introduced 
a PSC deletion vector into CPM1 to generate mutants defective in the production of PSC. 
The strain bearing this deletion (named CPM2) unexpectedly showed a dramatic defect in 
culture growth compared with that of wild-type B. fragilis or the mutant strain CPM1, as 
assessed by optical density and plating for colony-forming units (Figure 2.2A and data 
not shown). Furthermore, the mutant strain aggregated upon in vitro growth in culture 
(Supplementary Materials and Methods and Supplementary Figure 2.1). As previously 
shown for B. fragilis and other organisms, the absence of a capsule layer may expose 
surface adhesive molecules leading to aggregation (Patrick et al., 1996; Schembri et al., 
2005). We next investigated the possible mechanism(s) that may explain the growth 
attenuation resulting from deletion of polysaccharide biosynthesis in B. fragilis. When 
CPM2 was grown in laboratory culture media and sequentially passaged for 5 days, we 
observed a progressive restoration of growth (Figure 2.2A). Furthermore, passaged 
cultures displayed a recovery of CPS synthesis, as demonstrated by the presence of high-
molecular-weight species after immunoblot analysis of whole-cell lysates using antisera 
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raised against whole bacteria (Figure 2.2B). Thus, the absence of polysaccharide 
production and the attenuation of growth are either genetically or phenotypically linked, 
demonstrating the importance of polysaccharide molecules to B. fragilis. The 5-day-
passaged strain that exhibits wild-type growth characteristics may have acquired a 
genetic mutation to overcome the selective pressure of a growth defect; accordingly, we 
termed this revertant strain CPM3. 
 
Figure 2.2 | Phenotypic reversion of B. fragilis mutants defective in CPS production. (A) 
Growth curve of bacterial cultures after specific deletion of PSC from the mpi mutant CPM1 
shows severe growth attenuation of CPM2 (day1). A spontaneous reversion after serial passage of 
the bacterial cultures for 5 days restores in vitro growth (CPM3 day5). (B) Immunoblot analysis 
shows the overall reduction in CPS production in mpi mutant strains (CPM1 and CPM2) and the 
subsequent stepwise increase in polysaccharide production in CPM3 coincident with growth 
restoration. (C) Promoter analysis of CPM3 after 5 days of passage demonstrates that the PSB 
promoter undergoes reversion to the ‘‘on’’ orientation. CPM3 complemented with the mpi gene 
(CPM3 pFD340-mpi) displays restoration of phase variation at every promoter. (D) Immunoblot 
analysis with specific antisera shows the loss of PSB expression in CPM1 and a spontaneous 
recovery of PSB production under the selective pressure imposed by psc deletion (CPM2 day1). 
A phenotypic enrichment of PSB expression is found in CPM3. (E) Flow cytometry analysis of 
surface-displayed PSB reveals expression in nearly all bacterial cells after reversion in CPM3 but 
in only 7.4% of wild-type cultured cells. Black histograms represent control antibody staining; 
gray histograms (α-PSB) show PSB on the surface of B. fragilis CPM3. 
 
Promoter Inversion Occurs in the Absence of Mpi.  
What mediates polysaccharide expression in an mpi mutant strain? Initially, we 
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tested the hypothesis that alternate promoters directed in the ‘‘off’’ orientation may be 
driving transcription of capsular polysaccharides in CPM3. Promoter fusions to 
transcriptional reporters determined that ‘‘off’’-oriented promoters were incapable of 
mediating polysaccharide expression (Supplementary Figure 2.2). To examine the 
possible existence of a pathway secondary to Mpi that is capable of catalyzing promoter 
inversion, we screened the promoters of polysaccharide operons in CPM3 for their ‘‘on’’ 
or ‘‘off’’ orientation. We were surprised to observe that the promoter upstream of the 
PSB biosynthesis locus displayed a reversion to the ‘‘on’’ orientation in CPM3 (the mpi 
mutant background), but only after PSC deletion (Figure 2.2C: Upper). Only the PSB 
promoter reverted in 8 of 10 trials (PSD and PSH once each); thus, there appears to be a 
requirement for production of at least one capsular polysaccharide, with a strong (but not 
absolute) bias for PSB production in the absence of Mpi. Immunoblot analysis of whole-
cell lysates using antiserum specific to PSB demonstrated the phenotypic production of 
PSB (Figure 2.2D). CPM3 exhibited recovery of all Mpi-regulated promoter inversions 
when mpi was provided in trans (Figure 2.2C: Lower). To quantify the frequency of 
reversion, we used flow cytometry to enumerate the proportion of bacteria expressing 
PSB on their surfaces. Unlike wild-type cultures, in which only 7.4% of cells in a mixed 
population express PSB, nearly all CPM3 revertants assembled PSB as part of their 
bacterial envelopes (Figure 2.2E). A previously developed assay using cleavage of PCR 
products from invertible promoters demonstrated that the PSB promoter in strain CPM3 
is found exclusively in the ‘‘on’’ orientation (Supplementary Figure 2.3) (Krinos et al., 
2001). Quantitative-PCR digestion and flow cytometry showed that every bacterial cell 
expresses PSB, thus strongly suggesting that production of at least one capsular 
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polysaccharide is essential for B. fragilis viability. This reversion resulting in the 
expression of PSB occurred only after deletion of a non-Mpi-controlled polysaccharide 
(PSC). A further link between the expression of PSB and PSC was shown through the 
significant increase in PSC-expressing bacteria upon deletion of only PSB (B. fragilis 
9343ΔPSB), as measured by flow cytometry (Supplementary Figure 2.4). Taken together, 
these data demonstrate that B. fragilis has developed a profound and unusual requirement 
for the production of at least one capsular polysaccharide. 
 
B. fragilis employs multiple pathways for capsular polysaccharide expression. 
 The finding that the PSB promoter reverted to the ‘‘on’’ orientation in CPM3 
suggests that this strain acquires a ‘‘gain-of-function’’ phenotype to invert promoters 
under the physiologic stress of multiple polysaccharide deletion. To test whether CPM3 
has the ability to catalyze promoter recombination in the absence of mpi, we introduced a 
reporter plasmid with the PSB promoter in the ‘‘off’’ orientation into several B. fragilis 
strains. We measured inversion of the PSB promoter within the plasmid from ‘‘off’’ to 
‘‘on’’ orientation by PCR. The increased activity of promoter inversion in CPM3 was 
evidenced by recombination of the PSB promoter reporter, similar to the function found 
in wild-type bacteria (Figure 2.3A). CPM1, also deleted in mpi but not displaying a 
selective pressure to revert to polysaccharide production, is incapable of flipping the 
‘‘off’’- positioned PSB promoter. Furthermore, analysis of reporter plasmids for the 
remaining polysaccharide promoters illustrates that they are incapable of flipping to the 
‘‘on’’ orientation in CPM3 (Supplementary Figure 2.5), corroborating the specificity of 
CPM3’s activity for the PSB promoter. 
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Figure 2.3 | An Mpi-independent pathway for promoter inversion. (A) Upon introduction of 
reporter plasmid pCK56 (containing the PSB promoter in the ‘‘off’’ orientation), wild-type B. 
fragilis and CPM3 are competent to mediate conversion of the ‘‘off’’ promoter to the ‘‘on’’ 
position. CPM1 (Δmpi) lacks the ability to invert the locked-off psb promoter. (B) Phylogenetic 
analysis demonstrating the relatedness of the three serine site-specific recombinases (Ssr) in B. 
fragilis NCTC9343 generated by CLUSTALW analysis. The percent identity values indicate 
direct sequence comparisons of Ssr3 and Ssr1 to Mpi, respectively. (C) PCR products from a 
reporter plasmid containing the psb promoter in the ‘‘off’’ orientation and each of the Mpi 
homologues, Ssr1 and Ssr3. The psb promoter inverts in B. vulgatus only in the presence of Ssr3. 
Ssr3 overexpression in wild-type B. fragilis shows an increase in inversion activity. (D) PCR 
promoter orientation assay of CPM1 complemented with ssr3 (CPM1 pFD340-ssr3). All Mpi-
regulated promoters in the ‘‘off’’ orientation undergo phase variation when Ssr3 is constitutively 
expressed. Compare complementation to the expression of Mpi (Figure 2.1B). 
 
In addition to mpi, the genome sequence of the prototype B. fragilis strain 
NCTC9343 has been shown to contain two other serine site-specific recombinase genes: 
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ssr1 and ssr3 (also known as finB) (Figure 2.3B) (Cerdeno-Tarraga et al., 2005; Coyne et 
al., 2003). We hypothesized that one of these homologues may serve the nonredundant 
function of catalyzing recombination at invertible promoters in the absence of Mpi. To 
determine whether either gene product could mediate promoter inversion, we used 
reporter plasmids with the PSB promoter in the ‘‘off’’ orientation that also expressed 
either Ssr1 or Ssr3. These reporter constructs were subsequently introduced into B. 
vulgatus, a related species previously shown to be incapable of inverting the 
polysaccharide promoters of B. fragilis (Coyne et al., 2003). As demonstrated in Figure 
2.3C, Ssr1 was unable to mediate PSB promoter inversion in B. vulgatus, as assessed by 
PCR. In contrast, the expression of Ssr3 was sufficient to catalyze this reaction. The 
ability of Ssr3 to facilitate promoter inversion is consistent with the previous observation 
that this molecule binds to invertible promoters upstream of polysaccharide biosynthesis 
operons in B. fragilis (Patrick et al., 2003). 
We next investigated whether Ssr3 was capable of mediating inversion of the 
other capsular polysaccharide promoters in mpi deletion mutants. ssr3 was cloned into 
the expression vector pFD340 and was ectopically overexpressed in CPM1 (with all 
Mpi-regulated invertible promoters in the ‘‘locked-off’’ orientation). As shown by PCR 
analysis using promoter-specific primers, Ssr3 is capable of catalyzing recombination at 
all Mpi-regulated invertible promoters in the absence of Mpi (Figure 2.3D). The recovery 
of phase variation is also recapitulated in the mutant strain CPM3 (Supplementary Figure 
2.6). In addition to capsular polysaccharides, it has been shown that Mpi regulates 
promoter inversion at six additional genomic loci, the products of which all encode for 
unknown proteins. Mpi is capable of catalyzing promoter inversion at all of these sites; 
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Ssr3 is able to flip five of the six promoters, again demonstrating its ability to substitute 
for the lack of Mpi (Supplementary Figure 2.7). None of these ORFs encode for predicted 
surface proteins, and, unlike capsular polysaccharides, none are affected by the deletion 
of PSC (data not shown). Taken together, in addition to Mpi, we have revealed that a 
second enzyme is capable of mediating promoter inversion in B. fragilis and appears to 
provide a ‘‘fail-safe’’ function to ensure production of capsular polysaccharides. 
 
Mutants expressing a single capsular polysaccharide are defective for intestinal 
colonization of animals.  
It has been proposed that control of multiple polysaccharide loci through 
promoter inversion allows for the generation of extensive surface diversity during 
bacterial colonization of the mammalian gastrointestinal tract (Krinos et al., 2001; 
Kuwahara et al., 2004; Cerdeno-Tarraga et al., 2005). We reasoned that if the purpose of 
this system is to generate a multiplicity of surface structures (256 possible combinations 
of the 8 known polysaccharides), the homogeneous polysaccharide-expressing strains of 
B. fragilis we have created may display defects during colonization. Initially, germ-free 
mice (animals born and raised in the absence of microbial contamination) were readily 
colonized to similar levels by wild-type and mutant strains upon mono-association with 
bacteria (Figure 2.4A). Thus, all strains are competent for growth in animals. However, 
germ-free animals provide a model for the direct comparison of two bacterial strains for 
initial colonization (mimicking the events after a sterile birth) and thus accurately reflect 
each strain’s capacity for competitive colonization without the confounding effects of a 
complete microbiota. We co-associated germ-free animals with wild-type and mutant B. 
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fragilis strains and compared their ability to establish intestinal colonization. Competition 
experiments between wild-type and CPM1 strains demonstrated that wild-type B. fragilis 
quickly outcompeted the single-polysaccharide (PSC)-producing CPM1 strain in terms of 
intestinal colonization (Figure 2.4B). After 7 days, 95% of the bacteria recovered from 
the competition experiment in germ-free animals were wild-type organisms. Coculture of 
wild-type bacteria with CPM1 during serial passage in laboratory media consistently 
resulted in no growth defect at any time point (Figure 2.4C); this finding illustrates that 
the colonization phenotype observed is due to factors found in the intestinal environment 
of animals. The same phenotype for co-colonization is also observed for CPM3, which 
expresses only PSB (Supplementary Figure 2.8), as well as for a previously characterized 
PSA-only-expressing strain Δmpi mut44 (data not shown) (Coyne et al., 2003). Thus, 
expression of PSA, PSB, or PSC alone is insufficient to allow bacterial competition 
against wild-type B. fragilis. 
We next sought to determine whether the colonization defect for CPM1, a single-
polysaccharide-producing mutant of B. fragilis, could be reversed by restoring expression 
of the variable surface polysaccharides with ectopic expression of either Mpi or Ssr3. In 
competitive co-colonization experiments, CPM1 strains complemented with Mpi or Ssr3 
rapidly outcompeted the PSC-only-producing mutant CPM1 (Figure 2.4 D and E). This 
result provides additional evidence that single-polysaccharide-expressing B. fragilis 
mutants exhibit severe defects in host colonization when challenged by the presence of a 
B. fragilis strain that can vary its surface polysaccharide expression. In summary, 
examinations within this article demonstrate that B. fragilis has a strong propensity to 
elaborate at least one surface polysaccharide for in vitro growth, and expression of a 
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single polysaccharide appears insufficient to allow bacterial colonization of the 
mammalian host comparable with that by wild-type bacteria. 
              
Figure 2.4 | Comparison of germ-free animal colonization by B. fragilis mutants 
with limited diversity of surface polysaccharides. (A) Counts of colony-forming units (CFU) 
recovered from feces of germ-free animals after oral inoculation of bacteria show the ability of 
both wild-type and mutant strains to colonize laboratory animals during mono-association. Filled 
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squares, wild-type B. fragilis 9343; open triangles, B. fragilis CPM1; open squares, B. fragilis 
CPM3. (B) Percentages of each strain recovered from feces of animals after dual colonization of 
wild-type B. fragilis and B. fragilis CPM1 strain, premixed at a 1:1 ratio before gavage. Upon 
plating on selective media, wild-type bacteria quickly outcompete CPM1. (C) Percentages of each 
strain recovered from laboratory media after daily serial passages during coculture demonstrate 
that CPM1 displays no growth defect in culture competition with wild-type B. fragilis. Overnight 
cultures were subcultured daily into fresh media at a 1:100 dilution. (D) Percentages of each 
strain recovered from feces of animals after dual colonization of CPM1 and CPM1 complemented 
with mpi. (E) Percentages of each strain recovered from feces of animals after dual colonization 
of CPM1 and CPM1 complemented with ssr3 in trans. 
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DISCUSSION 
The intestinal microbiota of humans contains 10 times more cells than the human 
body and 100 times the number of genes than the human genome (O’Hara and Shanahan, 
2006). Although we are beginning to understand the identities of microorganisms that 
inhabit the gastrointestinal tract, the mechanisms they use to establish colonization are 
almost entirely unknown. The Bacteroides represent one of the most numerically 
prominent constituents of the human microbiota, and all members of this genus encode 
multiple capsule loci and contain Mpi homologues (Xu et al., 2007). Are capsular 
polysaccharides key molecular components that mediate various interactions between 
symbiotic Bacteroides and their mammalian hosts? The importance of these molecules is 
suggested by our finding that B. fragilis requires expression of at least one capsular 
polysaccharide for in vitro growth. When we selected for a mutant that was genetically 
unable to express all seven Mpi-regulated polysaccharides, we observed that every viable 
cell phenotypically expressed the default polysaccharide PSC. When we deleted PSC in 
this strain, we were able to recover only a poorly growing strain that overcame its growth 
defect and reverted to express another polysaccharide. To our knowledge, this is the first 
demonstration that the lack of capsule expression adversely affects bacterial growth. We 
demonstrate that B. fragilis contains an alternative recombinase (Ssr3) that is capable of 
inverting polysaccharide promoters. We were, however, unable to generate mutants of 
Ssr3 (because it is present on a multicopy plasmid) to directly assess whether it is 
responsible for the CPM3 phenotype. Also, genomic sequencing of the PSB promoter or 
the ssr3 gene and upstream regulatory elements yielded no mutations between any of the 
CPM mutants and wild-type bacteria (data not shown). Importantly, Ssr3 can compensate 
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for the absence of Mpi in both catalyzing promoter inversion and complementing defects 
in animal colonization. An inhibition of growth upon capsule deletion, a redundancy of 
mechanisms to ensure capsule biosynthesis, and defects in colonization upon limiting the 
capsular polysaccharide repertoire attest to the evolutionary importance for regulation of 
surface architecture by B. fragilis during colonization. 
The bacterial cell envelope can be viewed as the structural interface between 
microorganisms and their countless environments, mediating essential functions required 
for microbial attachment and colonization (Mazmanian et al., 2001). The many examples 
of adherence mechanisms used by bacterial pathogens during infection include molecules 
such as pili, fimbriae, and surface proteins (Pizarro-Cerda and Cossart, 2006). However, 
mechanisms involved in the establishment of colonization by multitudinous and 
important symbiotic organisms remain largely uncharacterized. Pioneering work by 
Comstock and colleagues (Krinos et al., 2001) first demonstrated that B. fragilis contains 
at least eight distinct capsular polysaccharides; the recent findings from genome 
sequences that three other Bacteroides species contain multiple capsule structures 
indicate that this is a unique and distinguishing feature of these important human 
commensals (Xu et al., 2007). We demonstrate that B. fragilis, a numerically prominent 
symbiotic organism of the human microbiota, is attenuated for intestinal colonization 
when it can no longer express a diverse repertoire of surface structures. Specifically, our 
data show that B. fragilis strains able to synthesize only a single polysaccharide cannot 
compete with wild-type bacteria for survival in the gastrointestinal tract of germ-free 
animals. Restoration of surface diversity in these mutants through complementation with 
either Mpi or its alternative homologue, Ssr3, rescues defects in both capsular 
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polysaccharide production and intestinal colonization. All sequenced Bacteroides contain 
orthologs of Mpi, presumably to create extensive surface diversity in these human 
commensals. Thus, our results with the well studied model organism B. fragilis may 
extend to other numerically significant commensal bacteria that inhabit the 
gastrointestinal tract of humans. Because the gut presents a dynamic and changing 
environment to colonizing organisms (i.e., nutrient changes, immune responses, 
bacteriophage attacks), perhaps sustained association of commensal bacteria with 
mammals requires intricate and dynamic processes unlike expression of a single toxin or 
adhesin used by many pathogens to establish acute infections. The regulation of surface 
architecture during intestinal colonization appears to be critically involved for 
establishing the commensal association of B. fragilis with its mammalian host. Recent 
efforts to define the ‘‘normal’’ sequence of colonization by bacterial species after birth 
have resulted in a deeper understanding of the evolutionary partnership between humans 
and their microbiota (Palmer et al., 2007). Our findings provide the framework to compel 
future studies to reveal the mechanisms by which the bacterial envelope contributes to the 
vital process of host–bacterial mutualism. 
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MATERIALS AND METHODS 
Bacterial strains, plasmids, and media. 
Bacterial strains and plasmids are described in Supplementary Table 2.2. 
 
Generation of strains CPM1 and CPM2. 
To create the B. fragilisΔmpi mutant CPM1, the plasmid pLEC80 (Supplementary 
Table 2.2) was mobilized fromDH5α cells by helper plasmid RK231 and conjugally 
transferred into a B. fragilis 9343ΔPSA mutant strain to generate a deletion of mpi and 
tsr19, a tyrosine site-specific recombinase that is not involved in Mpi-mediated capsular 
polysaccharide promoter inversion (Roche-Hakansson et al., 2007). Colonies selected for 
erythromycin resistance (Emr), indicating integration of the suicide vector into the host 
chromosome, were passaged for 5 days and then plated on nonselective medium (BHIS). 
The resulting colonies were replica-plated to BHIS containing Em, and Ems (sensitive) 
colonies were screened by PCR to distinguish wild-type revertants from strains with the 
desired mutation. To create mutant CPM2, a portion of the PSC locus was deleted from 
CPM1 by using plasmid pMJC2Δ.1 (Supplementary Table 2.2). Complementation studies 
with mpi and ssr3 were performed by cloning each gene into the B. fragilis–Escherichia 
coli shuttle plasmid pFD340 (Supplementary Table 2.2). 
 
Flow cytometry. 
For surface staining, cell preparations were washed twice in ice-cold FACS buffer 
(PBS with 2% FBS) and resuspended in 100 µl of the same buffer. A total of 1×107 cells 
were incubated with rabbit polyclonal antisera to PSB and PSC at a 1:100 dilution for 30 
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min at 4°C. Cells were then washed, incubated with goat anti-rabbit fluorochrome-
conjugated secondary antibodies, and analyzed by flow cytometry with an FC500 
cytometer. 
 
Germ-free animal colonization experiments. 
Male Swiss–Webster germ-free mice were purchased from Taconic Farms. Animals were 
screened for bacterial, viral, and fungal contamination by Gram staining, degenerate 
PCR, RapID ANA II System analysis, and plating of fecal samples under aerobic and 
anaerobic conditions. Animals were housed in gnotobiotic chambers or microisolator 
cages, and all food and bedding were sterilized by autoclave. Erythromycin (10 µg/ml) 
and gentamicin (100 µg/ml) were added to sterile drinking water. All Bacteroides strains 
(naturally resistant to gentamicin) contained the plasmid pFD340 conferring 
erythromycin resistance. Eight- to 13-week-old mice were orally inoculated with ~ 1×108 
colony-forming units of bacteria harvested from a log-phase culture and resuspended in 
PBS with 1.5% NaHCO3. At each time point after bacterial introduction to animals, fresh 
fecal samples were collected, serially diluted, and plated for colony-forming units. To 
discern between strains, we introduced a plasmid pFD340-cat (Supplementary Table 2.2), 
which confers chloramphenicol resistance. One hundred individual colonies were patched 
onto BHIS agar with erythromycin and chloramphenicol to determine the ratio between 
strains during colonization. All animals were cared for under established protocols using 
Institutional Animal Care and Use Committee guidelines of Harvard Medical School and 
the California Institute of Technology.
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Supplementary Figure 2.1 | (A) Wild-type and CPM1 (Δmpi) strains display no 
aggregation in overnight liquid culture whereas CPM2 (Δmpi, Δpsc) aggregates to each 
other and sinks to the bottom of the culture tube. Five-day passage in culture allows this 
phenotype to revert (day-5 CPM3). (B) The autoaggregation phenotype of day-1 CPM2 
liquid culture and the subsequent reversion of the phenotype in day-5 CPM3 liquid 
culture are quantitatively determined by optical density measurements. 
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Supplementary Figure 2.2 | Transcriptional reporter assay shows that invertible 
promoters do not possess activity when locked in the "off" orientation. Transcriptional 
reporter fusions of all seven Mpi-regulated polysaccharide promoters in the "locked-off" 
orientation (i.e., mutated in the inverted repeat sites) with the xylE gene of Escherichia 
coli cannot support transcription in wild-type B. fragilis. Furthermore, introduction of the 
same "locked-off" reporter constructs into strain CPM3 once again results in lack of XylE 
expression (data not shown). These results demonstrate the absence of an additional 
promoter with the opposite orientation. "Locked-on" promoter fusions in wild-type and 
CPM3 organisms serve as assay controls. 
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Supplementary Figure 2.3 | EtBr-stained agarose gel electrophoresis analysis of the 
PSB invertible promoter region from CPM1 and CPM3 chromosomal DNA is amplified 
with PCR using primers B1 and B5 (Supplementary Table 2.1). The preferred orientation 
of the promoter can be quantitatively determined when digested with restriction 
endonuclease (RsaI), which cleaves the fragment asymmetrically between the inverted 
repeat elements. PCR-digestion assay for the PSB invertible promoter region 
demonstrates that, whereas the psb promoter is completely in the "off" orientation in 
strain CPM1 (Δmpi), as also shown by immunoblot and flow cytometry, serially passaged 
CPM3 (Δmpi, Δpsc) mutant strain displays only "on" promoters. 
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Supplementary Figure 2.4 | Flow cytometry analysis of surface polysaccharides shows 
PSC expression in > 70% of bacterial cells after the specific mutation of only the psb 
locus (B. fragilis 9343ΔPSB) but in only 4.2% of wild-type cultured cells (Figure 2.1D). 
Thus, the expression of PSB and PSC is phenotypically linked. Black histogram 
represents control staining; gray histogram shows PSC on the surface of B. fragilis 
9343ΔPSB. 
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Supplementary Figure 2.5 | PCR analysis of the reporter plasmids containing one of the 
six invertible capsular polysaccharide promoters (psa, psd, pse, psf, psg, and psh) in the 
"off" orientation. Upon introduction into bacteria, all six of the "off"-oriented invertible 
CPS promoters flip to the "on" orientation in wild-type B. fragilis but not in the Δmpi 
mutant strains, CPM1 and CPM3. The recombination of the invertible promoter in CPM3 
is specific to psb. The orientation of the promoter within the reporter constructs was 
analyzed from JM109 as a negative control. 
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Supplementary Figure 2.6 | EtBr-stained agarose gel electrophoresis of PCR products 
generated from chromosomal DNA of B. fragilis mutant CPM3 (Δmpi, Δpsc) 
complemented with ssr3 gene (CPM3 pFD340-ssr3) with specific primers for both the 
"on" and the "off" orientations for each polysaccharide promoter. All Mpi-regulated 
promoters in the "off" orientation previously demonstrated by the PCR analysis of the 
chromosomal DNA of CPM3 (Figure 2.2C) undergo phase variation at each promoter 
when Ssr3 is constitutively expressed at a high level. 
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Supplementary Figure 2.7 | PCR orientation assay of B. fragilis mutant CPM1 (Δmpi), 
CPM1 complemented with mpi gene (CPM1 pFD340-mpi), and CPM1 complemented 
with ssr3 gene (CPM1 pFD340-ssr3) with specific primers for both the "on" and the "off" 
orientations at each of the six Mpi-controlled regions (Coyne et al., 2003). In the mpi 
mutant strain, all MCRs (Mpi-controlled regions) are locked to either "on" or "off" 
orientation. These promoters undergo phase variation at each promoter when Mpi is 
expressed ectopically (CPM1 pFD340-mpi). When Ssr3 is expressed under the pFD340 
promoter, all MCRs with an exception of the MCR1 recover their ability to invert (CPM1 
pFD340-ssr3). 
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Supplementary Figure 2.8 | CPM3 (expressing only PSB) is outcompeted by wild-type 
bacteria in animal colonization but displays no in vitro growth defect in co-culture with 
wild-type strain. For animal cocolonization, bacterial strains were premixed at a 1:1 ratio 
of mutant to wild-type and gavaged into germ-free animals. At specified time points, 
fecal samples were diluted in BHIS media and plated. The ratio between the two strains 
from the recovered bacteria was analyzed by strain-specific PCR. For in vitro co-culture 
experiment, bacterial strains were premixed before culture at a 1:1 ratio and inoculated 
into BHIS laboratory media. Overnight cultures were subcultured daily into fresh media 
(at a 1:100 dilution) for serial passage and plated. The percentage of each strain 
recovered from laboratory media was analyzed by strain-specific PCR. All bacteria were 
used only after serial passage in culture for 5 days to allow for phenotypic reversion of 
CPM2. 
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Supplementary Table 2.1 | Sequences of primers used for PCR in this study (All 
primers listed 5’→3’) 
B. fragilis chromosomal DNA PCR promoter orientation assay primers 
Primer name Sequence Purpose 
A3 ACCTTTTTTCGACCTTTTCTAAAAATC  Inversion PSA promoter 
A4 ACAAAGGTAAGGCACATTTTTATAAC  Inversion PSA promoter 
C473 AGAAAACTCCTGGTCCTTCTTTG  Inversion PSA promoter 
B2 ACAGACTCCTTACCTTTGTTCAATCAAACG  Inversion PSB promoter 
B4 CCGGAATGCTCTGGCATATTTTTTCAGCTC  Inversion PSB promoter 
B6 GCGCTCAATACACCGGCAATACGAATAAC  Inversion PSB promoter 
D5 GCAGTTATGAAAATACCCTCTATCTTTGCG  Inversion PSD promoter 
D6 GTCACCTTTGATACGGACAAACTCACCCTC  Inversion PSD promoter 
D7 GTTTTTTCCATCTCAGTTTCATGGCTTCAG  Inversion PSD promoter 
E1 GCCTTTTCCGTTGCTTACTG  Inversion PSE promoter 
E3 CGTTGAGGATAACAGCAGCA  Inversion PSE promoter 
E4 AGGTATAAACTAAATTTTGATGTGCAA  Inversion PSE promoter 
F1 CGTTTCATGTAAGGCGGATT  Inversion PSF promoter 
F2 CAGAAGAGAACAGAAAACAAAATCA  Inversion PSF promoter 
F3 CCAGTTCAAAGCGGAAGAAG  Inversion PSF promoter 
G1 TTTGCTTGTTGTCCGTTTTG  Inversion PSG promoter 
G2 TCGAAACATAAAAGCAGACAGA  Inversion PSG promoter 
G3 ACCGCATAGCGTCAGTCTCT  Inversion PSG promoter 
H1 CTTTGCCAGTTCCCGTATGT  Inversion PSH promoter 
H2 TGATGAAATTCAGAACCGGATA  Inversion PSH promoter 
H3 CGCTCGTTCTTGACGATGTA  Inversion PSH promoter 
MCR1-1 TGTATCCGGAGGAATGTGTTATAC  Inversion MCR1 promoter 
MCR1-2 CGAGTGATTTATTACGAAAAAGGA  Inversion MCR1 promoter 
MCR1-3 CAACCTATAATTTTCCGGAGTAGG  Inversion MCR1 promoter 
MCR2-1 GGTATTAAATGAGTAGCCCACCAC  Inversion MCR2 promoter 
MCR2-2 CTGTGCGAGAACTAAAGATTGTGT  Inversion MCR2 promoter 
MCR2-3 AGCAGTATATTTTGGAAGCGTAGG  Inversion MCR2 promoter 
MCR3a-1 GTCGTACAGGCTATCCGAGACTAT  Inversion MCR3a promoter 
MCR3a-2 TGTACAAAATGCAAAGGGAATAGA  Inversion MCR3a promoter 
MCR3a-3 TTAGGGTGGAAGGAGTATTTTCTG  Inversion MCR3a promoter 
MCR3b-1 GAAGGTAAAACCGATGTCAATAGC  Inversion MCR3b promoter 
MCR3b-2 GGGAGCCGATAAACTTCTGATAAT  Inversion MCR3b promoter 
MCR3b-3 TACGTAATTGCTGCCTACTTTACG  Inversion MCR3b promoter 
MCR4a-1 CACTCATGTAGTTCACCATTTTGG  Inversion MCR4a promoter 
MCR4a-2 CTGAAGGCCAAAGGAAGATATAAA  Inversion MCR4a promoter 
MCR4a-3 CCTGCCGTACTATTGAACGAGTAT  Inversion MCR4a promoter 
MCR4b-1 CTACTAGTGATGGGGGTACAGGAG  Inversion MCR4b promoter 
MCR4b-2 AACATCATTTTTACTCTCCGCACT  Inversion MCR4b promoter 
MCR4b-3 AGCCGACTGGAAGACATAGTTATT  Inversion MCR4b promoter 
 
Primers used for PSB promoter PCR-digestion assay B1  CCGGAATGCTCTGGCATATTTTTTCAGCTC B5  GCGGCAAACCAATACTTCTGTTGTTCAGA 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pCK56 PCR promoter orientation assay primers 
C7 GGGGACATTGTCTCTCTTTC 
VarB-F CGCAAAGATTACTTTTCCATTTACTTCG 
L103 GTTCGTTTGATTGAACAAAGGTAAGG 
 
Primers used to clone ssr1 and ssr3 (bold: 5’ addition) 
ssr1 F CCGGATCCAAACTTAGATACCATCAAAGAGAACC 
ssr1 R  TGGGATCCAAAAATGCGGAAATAGCTCAGT 
ssr3 F  AGGGATCCTTTTGCGAATAGTTGAATTTATGA 
ssr3 R  CAGGATCCAGCCCGACCTGAAAGGTAAC 
 
Primers used to amplify the promoter upstream sequences for XylE assay (bold: 5’ addition) 
PSA F ATCGGGATCCTTCGTTTATAAACACAAAGG PSA R  ATCGGGATCCGGATATTAAAAGTCGAGAG PSB F  ATCGGGATCCTTCGTTTGATTGAACAAAGG PSB R  ATCGGGATCCTATACTTGGGGAAATTTTC 
PSD F ATCGGGATCCATCGTCTAATTGAACCAAAGATAG PSD R  ATCGGGATCCATTCTATCAGCGCTTTTA PSE F  ATCGGGATCCTTCGTTTAATAGCACAAAGGTAT PSE R  ATCGGGATCCTTGGTTGACGAGAGGT PSF F  ATCGGGATCCTTCGTTTAATTGAACGCAAAGATA PSF R  ATCGGGATCCGTTCTTTGGGGACACCGG PSG F  ATCGGGATCCTTCGTCTATTTGAACGCAAAGATAA PSG R  ATCGGGATCCTATTTCAGAAAAGGACATTC PSH F  ATCGGGATCCTTCGTTCAATGGAACAAAGGTAA PSH R  ATCGGGATCCTCGGTTTTTTTTGCGTCATTTC 
 
Primers used in germ-free animal colonization competition and in vitro competition experiment 
CPM1-specific PCR primers 
ssr2-D1 AGTACTGATAACTCCGGTGACTCC 
ssr2-D6 ATGACATAGATAATGGGGAAGAGG 
CPM2-specific PCR primers 
C121 TATCCTGATGTTCTGCTTTTCCG 
C127 GGAGGATGTTTGAATTGGTGG  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Supplementary Table 2.2 | Plasmids and strains used in this study 
Strain or plasmid Description Reference 
or source 
E. coli DH5a F- f80dlacZDM15 D(lacZYA-argF) U169 deoR recA1 
endA1 hsdR17(rк- мк+) phoA supE44 l- thi-1 gyrA96 
relA1 
1 
Bacteroides fragilis NCTC 
9343 
Type strain 2 
B. fragilis 9343DPSA 9343 mutant with chromosomal deletion of PSA 
consecutive biosynthesis genes wzx-wcfS 
3 
B. fragilis 9343DPSA 
Dmpi.off (CPM1) 
9343DPSA mutant with chromosomal deletion of mpi-
tsr19 using pLEC80 deletion vector; invertible 
promoters for PSA, PSB, and PSD-H all in “off” 
orientation 
This study 
B. fragilis 9343DPSA 
DPSCDmpi.off (CPM2) 
9343DPSADmpi.off mutant with chromosomal 
deletion of PSC consecutive biosynthesis genes wcfD-
L, wzy, and orf5 
This study 
B. vulgatus ATCC 8482 Type strain 4 
PCR 2.1 Invitrogen TA-cloning vector; Kmr Ampr Invitrogen 
pNJR6 Bacteroides suicide vector; mob+ Tra- Kmr (E. coli) 
Emr (Bacteroides)  
5 
R751 Mobilizable mating plasmid to move constructs from 
E. coli to B. fragilis; Tra+ Tpr 
6 
RK231 Mobilizable mating plasmid to move constructs from 
E. coli to B. fragilis and B. vulgatus, RK2 derivative; 
Tra+ Tetr Kmr 
7 
pCK56 Modified pFD340 plasmid containing PSB invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pCK56-ssr1  Modified pCK56 plasmid containing the  ssr1 gene 
PCR amplified from B. fragilis NCTC 9343 cloned into 
a BamHI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pCK56-ssr3 Modified pCK56 plasmid containing the  ssr3 gene 
PCR amplified from B. fragilis NCTC 9343 cloned into 
a BamHI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pLEC80 Bacteroides Dmpi-tsr19 deletion vector; Ampr (E. coli) 
Emr (Bacteroides) 
This study 
pMJC2D.1 Bacteroides  DPSC deletion vector; Kmr (E. coli) Emr 
(Bacteroides) 
8 
pFD340 E. coli/B. fragilis shuttle vector, IS4351 promoter; 
Ampr (E. coli) Emr (Bacteroides)  
9 
pFD340-mpi Modified pFD340 plasmid containing the mpi gene 
PCR amplified from B. fragilis NCTC9343 cloned into 
a BamHI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-ssr3 Modified pFD340 plasmid containing the ssr3 gene 
PCR amplified from B. fragilis pBF9343 cloned into a 
BamHI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-cat Modified pFD340 plasmid containing the cat gene 
PCR amplified from E. Coli K12/pACYC184 
(accession #: X06403) cloned into a SmaI site; Ampr 
(E. coli) Emr (Bacteroides) 
This study 
pFD340-psa.off Modified pFD340 plasmid containing PSA invertible 
promoter region in the “off” position cloned into the 
This study 
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PstI site; Ampr (E. coli) Emr (Bacteroides) 
pFD340-psd.off Modified pFD340 plasmid containing PSD invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-pse.off Modified pFD340 plasmid containing PSE invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-psf.off Modified pFD340 plasmid containing PSF invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-psg.off Modified pFD340 plasmid containing PSG invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
pFD340-psh.off Modified pFD340 plasmid containing PSH invertible 
promoter region in the “off” position cloned into the 
PstI site; Ampr (E. coli) Emr (Bacteroides) 
This study 
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Supplementary Materials and Methods 
 
Bacterial Growth. Bacteroides strains were grown anaerobically on brain-heart infusion 
plates supplemented with hemin (5 µg/ml) and vitamin K1 (0.5 µg/ml) (BHIS). 
Gentamicin (200 µg/ml), erythromycin (5 µg/ml), and chloramphenicol (20 µg/ml) were 
added where appropriate. 
Autoaggregation Assay. All strains of B. fragilis were grown at 37°C in BHIS 
laboratory media. The cells were adjusted in BHIS to an OD of 0.5 at 600 nm and were 
split into two tubes of equal volume. After incubation at 37°C for 2 h, 2 ml of the upper 
suspension was transferred from one tube, and the OD was measured at 600 nm; in 
addition, 2 ml of the total bacterial suspension was taken from the other tube after 
mixing, and the OD was measured. Aggregation was expressed as {1 - (OD upper 
suspension/OD total bacterial suspension)}?100%. 
PCRs. Primers used for all PCRs are listed in Supplementary Table 2.1. 
Functional Promoter Analysis and XylE Assay. xylE reporter plasmid pLEC23 was 
used to assay for functional promoter activity (Krinos et al., 2001). Transcriptional 
fusions of all polysaccharide promoters locked in the "off" orientation (including a 300-
bp upstream sequence) were amplified and cloned into the BamHI site of pLEC23 
(primers listed in Supplementary Table 2.1). Promoter activity was examined by 
spectroscopy measuring the XylE-dependent colorimetric hydrolysis of the substrate 
catechol 2,3-dioxygenase. 
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PCR-Digestion Assay for PSB Promoter Orientation. To quantitatively determine the 
preferred orientation of the PSB promoter, PCR digestion assay was performed as 
described previously (Krinos et al., 2001). Briefly, PCR was performed with the primers 
B1 and B5, using chromosomal DNA from B. fragilis CPM1 and CPM3, which amplifies 
the PSB inverted region and some flanking DNA. The PCR product was digested with a 
restriction endonuclease (RsaI) that cleaves asymmetrically between the inverted repeat 
elements. The relative quantities of the resulting fragments directly correlate with the 
promoter orientations. These assays were performed a minimum of three times and 
yielded similar results. 
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ABSTRACT 
 Mammals harbor a complex gut microbiome, comprised of bacteria that provide 
nutritional, metabolic and immunologic benefits during colonization (Ley et al., 2006). 
Despite recent advances in sequence-based microbiome profiling (The Human 
Microbiome Project Consortium, 2012), virtually nothing is known about the molecular 
processes employed by symbiotic bacteria to permanently colonize the gastrointestinal 
(GI) tract. The gut can harbor a tremendous diversity of microbes (Yatsunenko et al., 
2012); however, we surprisingly find that mono-association of germ-free mice with 
single Bacteroides species saturates colonization. To identify bacterial mechanisms for 
species-specific saturable colonization, we devised an in vivo genetic screen and 
discovered a novel operon that is highly conserved among the intestinal Bacteroides, one 
of the most prominent gut bacterial genera of humans. We named this genetic locus the 
commensal colonization factors (ccf), which consist of transcriptional regulatory genes 
that control expression of a putative outer membrane protein complex. Deletion of the ccf 
genes in the model symbiont, Bacteroides fragilis, results in colonization defects in both 
germ-free and conventional mice. The ccf genes of B. fragilis are up-regulated during gut 
colonization, preferentially at the mucosal surface, supporting an in vivo function. Indeed, 
deletion of ccf genes leads to a defect in bacterial occupation of colonic crypts of mice 
and reduced mucosal association of mice. Remarkably, B. fragilis colonization of the gut 
after antibiotic depletion or gastroenteritis requires the CCF system, suggesting the niche 
within colonic crypts represents a reservoir for the gut microbiota following 
environmental stress. These findings reveal that intestinal Bacteroides have evolved 
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species-specific molecular interactions with the host that mediate stable and resilient gut 
colonization.  
  58 
INTRODUCTION 
Immediately upon birth, mammals enter an organized program of colonization to 
form complex microbial communities on environmentally exposed surfaces (Ley et al., 
2006). Recent international microbiome sequencing initiatives are revealing detailed 
inventories of the partnerships we share with diverse bacteria, across various body sites 
and human populations (The Human Microbiome Project Consortium, 2012; Qin et al., 
2010). We have learned that the relationships forged between humans and microbes over 
millennia create resilient microbiomes specific to individual hosts (Palmer et al., 2007; 
Dethlefsen et al., 2008). Accordingly, disturbances in the community composition of the 
gut microbiota (known as dysbiosis) have been linked to increased human disorders such 
as obesity, inflammatory bowel disease (IBD), malignancies and autism (Sekirov et al., 
2010). The ‘microbiota hypothesis’ proposes that modern lifestyle changes (e.g., Western 
diets, widespread antibiotic use, Caesarean sections) have reduced our exposure to 
health-promoting symbionts while enriching for disease-causing pathobionts (Round and 
Mazmanian, 2009). Although microbiome profiling has revealed critical links between 
gut bacteria and health, discovery of the molecular forces controlling intestinal 
colonization may be critical for addressing disturbing trends in human disease based on 
dysbiosis. 
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RESULTS 
Bacteroidetes is one of the most numerically abundant Gram-negative phyla in 
the mammalian gastrointestinal tract (Eckburg et al., 2005). Bacteroides thetaiotaomicron 
induces glycosylation of the intestinal epithelium to mediate architectural development of 
the gut (Bry et al., 1996), produces glycohydrolases that break down dietary 
carbohydrates for host nutrient utilization and promotes anti-microbial defenses to 
invading pathogens (Cash et al., 2006). Bacteroides fragilis is a gut mutualist that aids in 
host health by directing the cellular maturation of the developing immune system of the 
host (Mazmanian et al., 2005) and by protecting animals from inflammation in 
experimental models of IBD and multiple sclerosis (Mazmanian et al., 2008; Round and 
Mazmanian, 2010; Ochoa-Reparaz et al., 2010). Colonization by specific commensal 
bacteria may confer health in humans, and microbiomes with increased Bacteroidetes 
appear to be protected from some diseases (Takaishi et al., 2008; Turnbaugh et al., 2009; 
Penders et al., 2007). However, microbial processes by which these (or any) prominent 
human symbionts mediate life-long colonization of the gut remain unknown.  
To explore the mechanisms and dynamics of host-microbial symbiosis, we simulated 
microbiome assembly by sequentially introducing various Bacteroides species to germ-
free mice, and monitoring colonization over time. Animals were readily colonized with B. 
fragilis followed by B. thetaiotaomicron (Figure 3.1A) or Bacteroides vulgatus (Figure 
3.1B), and altering the sequence of microbial exposure did not affect results (Figure 
3.1C). Remarkably however, animals colonized with B. fragilis and subsequently 
exposed to the same species (marked by an antibiotic resistance gene) were resistant to 
super-colonization, with the challenging strain never reaching maximum levels and being 
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cleared over several days (Figure 3.1D). This property of ‘colonization resistance’ 
following mono-association was conserved in three other Bacteroides species examined 
(Figures 3.1E, Supplementary Figure 3.1), but not Escherichia coli (Supplementary 
Figure 3.2A). As conventional mice typically harbor 1011-1012 colony-forming units 
(CFU) per gram of cecal content (Ley et al., 2006) (100-fold greater than Bacteroides in 
mono-association), there appears to be no limitation for space or nutrients under these 
conditions. We thus hypothesized that each individual Bacteroides colonizes the gut via 
saturating a finite quantity of unknown host products (which could represent receptors, 
nutrients, etc.). If this were the case, we speculated that displacing the existing strain 
would open ‘niches’ for the challenge strain; indeed, treatment of B. fragilis mono-
associated mice with erythromycin promoted sustained colonization by the erythromycin-
resistant challenge strain (Figure 3.1F). These data suggest that Bacteroides colonize the 
gut in a species-specific and saturable manner, suggesting a highly co-evolved 
mechanism for symbiosis between mammals and their microbiota. 
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Figure 3.1 | Many Bacteroides species occupy finite and species-specific niche in the host 
intestine. Bacterial colonization level measured by CFU/g of feces over time.  Germ-free Swiss 
Webster mice are mono-associated with B. fragilis for 6 days and subsequently challenged orally 
with ~ 108 CFU of (A) B. thetaiotaomicron; (B) B. vulgatus; (D) B. fragilis. Germ-free Swiss 
Webster mice are mono-associated with B. vulgatus for 6 days and subsequently challenged 
orally with ~ 108 CFU of (C) B. fragilis; (E) B. vulgatus. Dashed line indicates the limit of 
detection at 100 CFU/g feces.  Results are representative of at least 2 independent trials (n=3 
animals/group). (F) Germ-free mouse mono-associated with erythromycin sensitive B. fragilis is 
orally challenged with ~ 108 CFU of erythromycin-resistant B. fragilis. Erythromycin treatment 
was administered orally by gavage (0.5 mg) and in drinking water (10 µg/ml) 12 hours after 
challenge. Results are representative of 3 independent trials (n=1 animal/group). 
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We sought to determine the molecules required for saturable-niche colonization. 
We have previously shown that a B. fragilis mutant that could not phase vary its multiple 
capsular polysaccharides was defective for establishment of colonization (Liu et al., 
2008). However, mice mono-associated with the capsular polysaccharide mutant 
appeared to be saturated for the B. fragilis niche similar to wild-type bacteria 
(Supplementary Figure 3.2B). Based on our discovery of self-exclusion by Bacteroides, 
we devised a functional in vivo screen to identify genetic factor(s) sufficient to mediate 
species-specific colonization. Mice were mono-associated with B. vulgatus, then 
challenged with B. vulgatus clones that contained a genomic library from B. fragilis (the 
scheme is depicted in Figure 3.2A). We reasoned that only those clones containing genes 
that conferred colonization by B. fragilis would persist, with the remainder being cleared 
from the gut. We screened 2,100 clones (in pools of 96 per mouse) each containing 9-10 
kilobases of DNA, providing a 3.8-fold coverage of the B. fragilis genome and 98% 
probability that a given DNA sequence is present in the library (see Equation 3.1). 
Remarkably, only two clones sustained colonization in animals and the rest were cleared. 
Sequencing the two isolates mapped to the identical genomic locus of B. fragilis with the 
minimal genetic element common to both DNA fragments containing five novel 
hypothetical open reading frames: BF3583, BF3582, BF3581, BF3580 and BF3579 
(Figure 3.2B). 
 
 
 
  63 
€ 
N = ln(1− P)
ln(1− iG )
=
ln(1− P)
ln(1− 9.5 ×10
3
5.2 ×106 )
= 2100 
P = 0.979 
Equation 3.1 | Optimal number of clones in the genomic library (Sambrook et al., 1989).  P 
denotes the probability of isolating a particular DNA sequence.  The total number of clones 
screened (N) is 2100; average insert size (i) is 9.5 kb and the B. fragilis genome size (G) is 
5.2×106 bp. 
 
 
Figure 3.2 | (A) Schematic of functional in vivo screen of the B. fragilis genome for mouse  
gut colonization. 9-10 kb fragments of B. fragilis genomic DNA generated by partial digestion 
with Sau3AI are ligated into E. coli-Bacteroides shuttle plasmid pFD340-catBII (Cmr).  Each 
individual clone is conjugally transferred into B. vulgatus generating a library of B. vulgatus 
carrying a unique B. fragilis genomic DNA fragment.  The library is screened for B. fragilis-
specific niche colonization phenotype in animals mono-associated with B. vulgatus. (B) The 
minimal genetic element common to the two clones (S16 and S22) that display colonization 
phenotype from the functional screen contains 5 previously unknown genes: BF3583, BF3582, 
BF3581, BF3580 and BF3579.  
 
Based on the protein sequence, BF3583 and BF3582 show similarity to a sigma (σ) 
factor/anti-σ factor gene pair that may control transcription of three downstream genes, 
which appear to be in an operon according to several operon databases such as 
MicrobesOnline (Price et al., 2005) and DOOR (Database of prOkaryotic OpeRons) 
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(Dam et al., 2007; Mao et al., 2009) (Supplementary Figure 3.3). BF3581 sequence 
shows strong homology to the SusC family of outer membrane proteins. BF3580 is a 
SusD homolog, an outer membrane lipoprotein often paired with SusC. Together, the 
Sus-like system is believed to bind and import a range of sugar molecules (Koropatkin et 
al., 2012; Martens et al., 2009; Shipman et al., 2000; Schauer et al., 2008). BF3579 
encodes for a putative chitobiase, suggesting a possible polysaccharide substrate for this 
system (Kawada et al., 2008). Comparative genomic analysis using the genes identified 
from the screen to query JGI’s Integrated Microbial Genomes database 
(http://img.jgi.doe.gov/cgi-bin/w/main.cgi) revealed conservation of similar clusters of 
genes among sequenced Bacteroidetes species (Figure 3.3). Homologous loci were 
identified within the genomes of B. fragilis, B. thetaiotaomicron, B. ovatus and B. 
vulgatus, all having displayed the colonization resistance phenotype (Figure 3.4). 
Therefore, we have identified a novel pathway in B. fragilis sufficient for species-specific 
colonization; moreover, this process may be shared by many intestinal Bacteroides. The 
genes are named ccfA-E, for commensal colonization factors. 
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Figure 3.3 | Phylogenetic tree based on BF3581 and BF3580 homology in the phylum 
Bacteroidetes. Labels indicate the locus ID of the BF3581 homologues. Amino acid sequences of 
BF3581and BF3580 are used to query sequenced genomes using JGI’s Integrated Microbial 
Genomes site (Markowitz et al., 2012). Genomic context adjacent to BF3581 and BF3580 
homologues with expected values less than 10-10 are examined for operon organization 
resemblance to BF3579-BF3583. For inclusion in the tree, candidate operons are required to have 
a downstream BF3579 homologue with at least one of either the F5/F8 Type C domain 
(pfam00754) or the domain of unknown function, DUF1735 (pfam08522), which are present in 
BF3579. Also, candidate operons are required to have a BF3582 homologue. These include anti-
sigma factors, IPT/TIG domain-containing transmembrane proteins (pfam01833), sensor histidine 
kinases, and transmembrane 6-bladed NHL-repeat beta-propellers (pfam01436). The legend 
refers to the type of transmembrane regulatory domain found upstream of the BF3581 
homologue. The sus operon (BT3702) from B. thetaiotaomicron is included as an outgroup. 
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Operons from redundant strains of single species and the 22 draft genomes of unnamed 
Bacteroides sp. Isolates are not included. Amino acid sequences of BF3581 and BF3580 
homologues are concatenated and locally aligned using MUSCLE (Edgar, 2004). The tree is 
constructed using PhyML (Guindon et al., 2010) and displayed using iTOL (Letunic and Bork, 
2007). 
 
 
Figure 3.4 | Comparative genomic analysis for homologues of the operon identified from the 
in vivo screen. Homologous operons in B. fragilis, B. thetaiotaomicron, B. ovatus, and B. 
vulgatus were selected from a phylogenetic tree constructed by querying the genomes in the 
phylum Bacteroidetes (Figure 3.3). 
 
To test if the putative structural genes (ccfC-E) are required for gut colonization, 
we generated in-frame deletion mutants of B. fragilis; ΔccfC, ΔccfD and ΔccfE. All 
strains exhibited normal morphology on solid agar medium and unimpaired growth in 
laboratory culture (data not shown). Germ-free mice were associated with individual 
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mutant strains, and subsequently challenged with WT B. fragilis. As previously shown, 
animals mono-colonized with WT B. fragilis completely cleared the challenge strain after 
30 days (Figure 3.5; 1st bars). However, animals mono-associated with ΔccfC or ΔccfD 
were permissive to colonization by WT bacteria (Figure 3.5; 2nd and 3rd bars), unlike the 
ccfE mutant (Figure 3.5; 4th bars). A deletion mutant in all three genes (B. fragilisΔCCF) 
also allowed WT B. fragilis to colonize (Figure 3.5; 5th bars). Similarly, ccfC-E mutant in 
B. vulgatus (ΔBVU0946-BVU0948) also permitted WT B. vulgatus colonization 
(Supplementary Figure 3.4; 1st and 2nd bars), demonstrating this system may be universal 
to this genus. When B. fragilisΔCCF mono-associated animals were challenged with the 
same mutant strain, the challenging bacteria were cleared (Figure 3.5; 6th bars). As there 
are multiple similar gene clusters in B. fragilis, this finding suggests that the CCF system 
we identified is necessary for colonization resistance, but redundant mechanisms may be 
mediated by the other ccf gene homologues in its absence (Figure 3.4). B. vulgatusΔCCF 
strain also prevented further colonization by the same mutant strain (Supplementary 
Figure 3.4; 3rd bar), again suggesting functional redundancy during colonization. This 
interpretation is consistent with the fact that challenge of B. fragilisΔccfC or ΔccfD with 
WT bacteria led to colonization that was two logs lower than mono-association (Figure 
3.5; 2nd and 3rd bars). Further, mono-colonization with a B. vulgatus strain expressing the 
B. fragilis ccf genes (ccfA-E) was unable to saturate B. fragilis-specific niche in the gut 
and permitted WT B. fragilis colonization (Supplementary Figure 3.4; 5th bar). These 
findings suggest that a single ccf locus is responsible for partial saturation of a broader 
species-specific niche (which could be host receptors, nutrients or spatial access to a 
  68 
niche, etc.). Based on its requirement for saturable colonization, we focused further 
studies on the primary ccf operon identified from the functional screen. 
 
 
Figure 3.5 | The ccf genes mediate saturable-niche colonization by B. fragilis. Germ-free 
Swiss Webster mice are mono-associated with WT or mutant strains deleted in the putative 
structural ccf gene(s) for 6–7 days and subsequently challenged orally with ~ 108 CFU of WT B. 
fragilis or mutant strain deleted in ccfC-E genes (BFΔCCF). 30 days after challenge, initial and 
challenge strains are quantified. Dashed line indicates the limit of detection at 100 CFU/g feces 
(n=3 animals/group). 
 
Virulence factors of pathogens are expressed upon animal infection. We 
speculated that the ccf genes may be induced in bacteria during animal colonization. 
Based on the previous observation that a population of B. fragilis associates with mucosal 
tissues (Round et al., 2011), we show that ccfB-E are preferentially expressed by bacteria 
in contact with the colon, with lower levels in luminal cecal content and feces (Figure 
3.6A). There was virtually no expression in laboratory culture, suggesting a role for the 
host factor(s) to activate the CCF system. ccfA and ccfB have strong homology to a 
bacterial σ factor/anti-σ factor pair, which regulate transcription by controlling RNA 
polymerase recruitment to specific promoters. In-frame deletion of ccfA led to highly 
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reduced expression of all genes in the operon during animal colonization (Figure 3.6B). 
Accordingly, mono-colonization of germ-free mice with ΔccfA mutant was permissive 
for challenge with WT bacteria, demonstrating a functional defect in the saturable-niche 
occupancy (Figure 3.6C).  Interestingly, an in-frame deletion mutation in ccfB also 
resulted in attenuated gene expression throughout the operon (Supplementary Figure 
3.5A), and a defect in saturable colonization of the gut (Supplementary Figure 3.5B). 
Thus, in vivo expression of the ccf operon near gut tissue may be critical for colonization 
fitness. If true, then challenging WT B. fragilis mono-associated mice with WT B. 
fragilis harvested from the gut of donor mice may enhance colonization. In contrast to 
laboratory grown bacteria (see Figure 3.1D), sustained colonization was conferred to 
bacteria recovered directly from animals (Figure 3.6D). These data suggest that sensing 
of host factors (possibly near the gut epithelium) activates transcription of the ccf genes 
and may promote persistent host association. 
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Figure 3.6 | ccf genes are preferentially expressed at the mucosal surface of the gut.  (A) 
qRT-PCR of the ccf gene expression levels normalized against 16S rRNA. Total RNA is 
extracted from feces, cecal content and colon tissues of the animals mono-associated with WT B. 
fragilis for 2 weeks (n=3 animals/group) and from laboratory culture. (B) qRT-PCR of the ccf 
gene expression levels from BFΔccfA mono-associated animal feces, cecal content and colon 
tissues (n=3 animals/group) and culture. (C) Fecal bacterial colonization levels measured from 
germ-free mice mono-associated with BFΔccfA and subsequently challenged with ~ 108 CFU of 
WT B. fragilis. (D) Fecal bacterial colonization level of germ-free mice mono-associated with B. 
fragilis and subsequently challenged orally with ~ 108 CFU of B. fragilis harvested from cecal 
content of another animal (n=3 animals/group, 1 donor). 
 
Increased expression of the ccf genes near colon tissue prompted us to investigate 
whether B. fragilisΔCCF displays a defect in mucosal association. Since each strain can 
mono-colonize germ-free mice equally, we used a competitive colonization approach to 
examine if the CCF system promotes bacterial localization to colonic tissue. Mice were 
mono-associated with either the WT or the ccf deletion strain, and both groups were 
subsequently challenged with WT B. fragilis. 24 hours after challenge, we observed the 
same relative numbers for challenge strains in feces of both groups (Figure 3.7A, B & C; 
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1st and 2nd bars). However, colon tissue-associated bacterial levels of the challenge strain 
were higher in animals pre-associated with the ccf mutant (Figure 3.7A, B & C; 3rd and 
4th bars). An increased tissue association in animals pre-colonized with the ccf mutant 
compared to WT bacteria suggests a colonization defect by the mutant strain specifically 
at the mucosal surface, but not in the lumen. Since luminal contents are constantly being 
expelled from the gut, we speculate that the CCF system mediates long-term colonization 
by localizing B. fragilis to the colonic epithelium. 
 
Figure 3.7 | Germ-free Swiss Webster mice are mono-associated with either (A) WT B. fragilis 
or (B) B. fragilis ΔCCF for 7 days and orally challenged with 108 CFU of laboratory culture WT 
B. fragilis. 1 day after challenge, feces and colon tissues (1 cm representative piece from 
ascending, transverse and descending colon) are harvested, mucus layer scraped off from the 
tissue and homogenized in PBS and plated on selective media for CFU determination (A, B). (C) 
Percentage of challenge strain from total bacteria is calculated by dividing the challenge strain 
counts from (A) and (B) with the sum of initial and challenge strain counts for each sample (n=8 
animals/group). ** indicates p value less than 0.01. 
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Symbiotic gut bacteria were historically believed to reside exclusively in the GI 
lumen and not make intimate contact with host tissue (Hooper, 2009). However, we have 
shown that B. fragilis occupies the colonic crypts of mono-associated mice (Round et al., 
2011) and recent studies have revealed numerous species colonize intestinal crypts of 
SPF mice (Pedron et al., 2012). Increased production of the ccf genes near mucosal tissue 
prompted us to explore the intriguing hypothesis that the CCF system mediates crypt 
occupancy by Bacteroides. We mono-colonized mice with B. fragilis and visualized 
bacterial localization in colon tissue using whole-mount confocal microscopy. A close 
look at a single crypt by analyzing z-stack images revealed a distinct cluster of WT B. 
fragilis deep within the channel of the crypt (Figure 3.8A). When WT B. fragilis mono-
associated animal colon was compared to that of B. fragilisΔCCF mono-associated mice, 
we saw drastically fewer crypt occupancies by the mutant bacteria (Figure 3.8B), 
suggesting that CCF system mediates specific crypt colonization by the bacteria. Two-
photon imaging of colon explants clearly demonstrated presence of WT B. fragilis on the 
surface of the epithelium and inside the crypt (Figure 3.9A). While both strains of B. 
fragilis associate with the surface of the epithelium, only WT bacteria are able to 
penetrate deep into the colonic crypts of mice (Figure 3.9A). Measuring the distance from 
the apical surface of the epithelium to the fluorescent signal revealed significantly greater 
penetration from the tissue surface by WT bacteria (Figure 3.9B). Collectively, these data 
suggest that the CCF system allows B. fragilis to reside in a specific niche within crypts 
during symbiotic colonization. 
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Figure 3.8 | B. fragilis colonization of the colon crypt is mediated by CCF. (A) 4% PFA fixed 
whole-mount colon tissues from WT B. fragilis mono-associated mice. The colon crypt is 
visualized by nuclear counterstaining with DAPI (blue) and F-actin counterstaining with 
phalloidin (green). Bacteria are visualized by IgY polyclonal antibody raised against B. fragilis 
(red). A z stack is reconstructed and bacteria harboring crypt is visualized from the side-view 
with a cartoon schematic on the right. (B) Confocal micrographs of 4% PFA fixed whole-mount 
colon tissues from germ-free, WT B. fragilis mono-associated or B. fragilisΔCCF mono-
associated mice stained for bacteria (red, arrows) with DAPI (blue) and phalloidin (green) 
counterstaining. Images are representative of seven different sites analyzed from at least two 
different colons. Scale bar: 10 µm. 
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Figure 3.9 | CCF mediates bacterial occupancy of a deep crypt space. (A) 3D reconstructions 
of B. fragilis mono-associated mouse colon crypts using two-photon microscopy. 
Fluorescence signals are detected on the apical surface of the epithelium (arrows) for both strains 
and in the crypt space (arrowhead) by WT bacteria. Scale bar: 10 µm. (B) Quantification of B. 
fragilis localization in the crypt space measured by the distance of the immune-reactivity signal 
from the epithelial surface. GF: germ-free mice. ND: not detected. **** indicates p value less 
than 0.0001. 
 
We next investigated the effects of the CCF system in the context of a complex 
microbiota, as germ-free mice represent an unnatural microbial status. Bacteroides 
species do not readily colonize most strains of specific pathogen-free (SPF) mice, namely 
BALB/c, Swiss Webster and C57BL/6, despite oral administration of high inoculums 
(Supplementary Figure 3.6A, C and data not shown). Furthermore, challenge of mono-
colonized mice with a complex mouse microbiota led to clearance of the WT. B. fragilis 
(Supplementary Figure 3.6B, D). As we previously observed empirically that B. fragilis 
can colonize SPF Rag-/- mice, which lack mature B and T lymphocytes, and SPF non-
obese diabetic (NOD) mice, immunocompetent animal model for type 1 diabetes, we 
introduced either WT or ccf mutant B. fragilis at equal inoculums into separate groups of 
animals. Only WT B. fragilis stably colonized Rag-/- mice, whereas B. fragilisΔCCF 
established a significantly lower colonization in the gut (Figure 3.10A). Co-inoculation of 
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equal numbers of WT and ccf mutant bacteria into Rag-/- mice also resulted in rapid 
clearance of the mutant strain from the gut (Figure 3.10B), demonstrating a cell intrinsic 
defect that could not be complemented in trans by WT bacteria. NOD animals were also 
preferentially colonized by WT B. fragilis compared to ccf mutant strain, when given to 
separate groups of animals (Figure 3.10C) or together in equal amount (Figure 3.10D). 
These data show that deletion of the ccf genes severely compromises B. fragilis 
colonization of mice with a complex microbiota, independent of the adaptive immune 
system. A profiling study comparing Rag-/-, NOD and C57BL/6 SPF microbiota, though 
beyond the scope of this study, may reveal specific microbes absent in Rag-/- or NOD 
mice that directly compete with B. fragilis for saturable colonization. 
 
Figure 3.10 | B. fragilis colonization of the animal harboring a complex microbiota is 
attenuated in the absence of CCF. (A) SPF Rag-/- mice are given either WT B. fragilis or B. 
fragilisΔCCF by single oral gavage and the colonization level assessed by qPCR (n=4 
animals/group). *** indicates p value less than 0.001. (B) SPF Rag-/- mice are given equal dose 
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of WT B. fragilis and B. fragilisΔCCF by single oral gavage and the colonization level assessed 
by qPCR (n=4 animals/group). *** indicates p value less than 0.001. (C) SPF NOD mice are 
given either WT B. fragilis or B. fragilisΔCCF by single oral gavage and the colonization level 
assessed by qPCR (n=4 animals/group). * indicates p values less than 0.05. (D) SPF NOD mice 
are given equal dose of WT B. fragilis and B. fragilisΔCCF by single oral gavage and the 
colonization level assessed by qPCR (n=4 animals/group). * indicates p values less than 0.05. 
 
During symbiosis with mammals, the microbiota may be confronted by rapid 
environmental changes with potentially adverse consequences to bacteria, such as 
antibiotic intake, dietary changes, gastrointestinal infection/inflammation, etc. We 
speculate that Bacteroides species evolved the ccf genes to promote long-term host 
colonization. Gastroenteritis is commonly experienced by most humans multiple times 
throughout life, and is known to perturb the microbiota (Sekirov and Finlay, 2009). To 
test if resiliency of B. fragilis colonization is CCF-dependent, we used Citrobacter 
rodentium infection of SPF mice to mimic human gastrointestinal infection (Schauer and 
Falkow, 1993; Mundy et al., 2005). Using an antibiotic treatment protocol that does not 
sterilize the gut but promote colonization of SPF mice by Bacteroides (Bloom et al., 2011), we were able to simultaneously colonize mice with equivalent levels of WT and 
ccf mutant bacteria. Mice were subsequently infected orally with C. rodentium, and 
colonization of B. fragilis was monitored. Consequently, WT bacteria declined in number 
following the 2-week course of infection, but returned to maximal levels 3-4 weeks post 
infection (Figure 3.11A). Importantly, the B. fragilisΔCCF strain was completely cleared 
from the mouse gut following gastroenteritis but not when animals were given PBS as 
control (Figure 3.11A, B). These results reveal that the CCF system establishes 
colonization resiliency by gut Bacteroides following disruption of the microbiome, 
representing the seminal example for a bacterial process that mediates stable host-
microbial association. 
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Figure 3.11 | The CCF system mediates B. fragilis persistence after perturbation of 
microbiota. (A) Real-time qPCR analysis of bacterial colonization levels in 
feces from SPF SW mice that were antibiotic treated to allow co-association with WT B. fragilis 
and B. fragilisΔCCF. After 6 days, mice were infected with Citrobacter rodentium (n=4 
animals/group). Results are representative of 2 independent experiments. (B) Real-time qPCR 
analysis of bacterial colonization levels in feces from SPF SW mice that were antibiotic treated 
and co-associated with WT B. fragilis and B. fragilisΔCCF. After 6 days, mice were given PBS 
(n=4 animals/group). Results are representative of 2 independent experiments. All error bars 
indicate standard error of the mean (SEM). 
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DISCUSSION 
Evolution has bound microbes and man in an inextricable relationship, and recent 
evidence reveals specificity and stability of the human microbiome (The Human 
Microbiome Project Consortium, 2012; Yatsunenko et al., 2012). However, the molecular 
mechanism(s) by which stable microbiomes assemble are unknown. Our findings reveal a 
novel, evolutionarily conserved outer membrane complex required for persistent 
colonization of the mammalian gut by the numerically prominent Bacteroides. Homology 
to the Sus family of proteins suggests a role for CCF in uptake and utilization of glycans. 
Sus genes represent the archetype for sugar acquisitions mechanisms by intestinal 
bacteria, and are widely duplicated in gut Bacteroides (88 gene clusters in B. 
thetaiotaomicron, encompassing 18% of the genome). Although Sus systems in 
Bacteroides mediate foraging of host mucus as an energy source (Koropatkin et al., 
2012), their contribution to microbial colonization have not been investigated. Our 
discovery of CCF-dependent saturable colonization within, but not between, species 
suggests a model whereby Bacteroides evolved specific Sus-like systems to utilize 
unique and limiting sugars for association with the host. Future work will aim to identify 
the substrates for various CCF systems. Based on the findings that ccf genes are 
preferentially expressed in proximity to mucosal tissues and B. fragilis associates with 
colonic crypts, we find it likely that host factors (and not dietary substrates) may induce 
expression of the CCF system. Perhaps unique glycan structures found within colonic 
crypts serve as a carbon source for growth and/or adherence to host tissue. Finally, we 
propose that the ccf genes evolved to promote stable and resilient colonization, as crypt-
associated bacterial reservoirs may represent ‘founder’ cells that repopulate the gut 
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following disruption of the microbiome by antibiotics or enteric infections. 
Understanding the evolutionary forces that mediate commensal colonization may 
advance therapies to correct dysbiosis, providing potentially novel therapies for 
numerous human diseases. 
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MATERIALS AND METHODS 
Bacterial strains, plasmids and culture conditions.   
Bacterial strains and plasmids are described in Supplementary Table 3.1. 
Bacteroides strains were grown anaerobically at 37°C for two days in brain-heart 
infusion broth supplemented with 5 µg/ml hemin and 0.5 µg/ml vitamin K (BHIS), with 
gentamicin (200 µg/ml), erythromycin (5 µg/ml), chloramphenicol (10 µg/ml) and 
tetracycline (2 µg/ml) added where appropriate.  Escherichia coli JM109 containing 
recombinant plasmids were grown in LB with ampicillin (100 µg/ml) or kanamycin (30 
µg/ml). Citrobacter rodentium DBS100 strain was grown in LB at 37°C for 24 hours.   
 
Mice.  
Germ-free Swiss Webster mice were purchased from Taconic Farms 
(Germantown, NY) and bred in flexible film isolators. For gnotobiotic colonization 
experiments, germ-free mice were transferred to freshly autoclaved microisolator cages 
with sterile food and bedding, supplemented with 10 µg/ml of erythromycin and 100 
µg/ml of gentamicin in drinking water. Male SPF (Specific Pathogen-Free) C57BL/6 
mice and Swiss Webster mice were purchased from Taconic Farms. Male SPF 
NOD/ShiLtJ mice and Rag-/- C57BL/6 mice were purchased from the Jackson 
Laboratory. All procedures were performed in accordance with the approved protocols 
using IACUC guidelines of the California Institute of Technology. 
 
Construction of chromosomal library and screen.  
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Genomic DNA was isolated from overnight culture of B. fragilis using a 
commercial kit (Wizard® Genomic DNA Purification Kit, Promega). 20 µg of genomic 
DNA was incubated with 4U of Sau3AI for 5, 10, 15, or 20 minutes at 37°C in 50 µl 
volume and the partially digested genomic DNA was separated by electrophoresis on 
0.7% agarose gel.  9–10 kb fragment DNA was excised and recovered from the agarose 
gel (ZymocleanTM Gel DNA Recovery Kit, Zymo Research).  Insert DNA was ligated to 
BglII site of plasmid vector (pFD340-catBII, Supplementary Table 4.1), transformed into 
E. coli and amplified on LB-ampicillin plate.  Individual clones from the plasmid library 
were mobilized from E. coli to B. vulgatus by conjugal helper plasmid RK231 generating 
a library of B. vulgatus hosting B. fragilis chromosomal DNA fragments consisting of 
approximately ~ 2100 clones. To screen the library in vivo, pools of 96 clones (106 CFU 
of each clone) were gavaged into 22 germ-free Swiss Webster mice (108 CFU per animal) 
pre-colonized with B. vulgatus pFD340 for 1–2 weeks. Two weeks after gavage, fresh 
fecal samples were plated on BHIS agar plate containing chloramphenicol to select for 
clones with colonization phenotype.  
 
Generation of ccfA, ccfB, ccfC, ccfD, ccfE and ccfC-E (ΔCCF) deletion mutants.  
~ 2 kb DNA segments flanking the region to be deleted were PCR amplified using 
primers listed in Supplementary Table 3.2.  Reverse primer of the left flanking DNA and 
forward primer of the right flanking DNA were designed to be partially complementary 
at their 5’ ends by 18–21 bp. Fusion PCR was performed using the left and right flanking 
DNA (~ 300 ng each after gel purification) as DNA template and forward primer of the 
left flanking DNA and reverse primer of the right flanking DNA (Wurch et al., 1998).  
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The fused PCR product was cloned into BamHI or SalI site of the Bacteroides conjugal 
suicide vector pNJR6 and mobilized into B. fragilis. Colonies selected for erythromycin 
resistance (Emr), indicating integration of the suicide vector into the host chromosome 
were passaged for five days and then plated on nonselective medium (BHIS). The 
resulting colonies were replica plated to BHIS containing Em, and Ems (erythromycin 
sensitive) colonies were screened by PCR to distinguish wild-type revertants from strains 
with the desired mutation.  The same strategy was employed to generate ΔccfC-E 
deletion mutant from B. vulgatus.   
 
Quantitative RT-PCR.   
Total RNA was extracted from mid-log-phase bacterial culture using ZR 
Fungal/Bacterial RNA MiniPrepTM (Zymo Research), feces and cecal content from mice 
using ZR Soil/Fecal RNA MicroPrepTM (Zymo Research), and mouse colon tissues after 
removing luminal content by gently scraping the mucosal surface and PBS rinse using 
Trizol (Invitrogen).  cDNA was made using an iSCRIPT cDNA synthesis kit per 
manufacturer’s instructions (Bio-Rad).  All q-PCR reactions were performed in ABI 
PRISM 7900HT Fast Real-Time PCR System (Applied Biosystems) using Power SYBR 
Green PCR Master Mix (Applied Biosystems).  Gene-specific primers are described in 
Supplementary Table 3.2.   
 
Gnotobiotic animal colonization experiments.  
8–12 week old germ-free Swiss Webster mice were either mono-associated or 
sequentially bi-associated with Bacteroides strains by oral gavage (~ 108 CFU of each 
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bacterial strain harvested from a log-phase culture and resuspended in PBS with 1.5% 
NaHCO3). All Bacteroides strains used to colonize germ-free animals were resistant to 
gentamicin inherently, and to erythromycin by plasmid.  Unless otherwise indicated, the 
initial strains carried pFD340-cat (chloramphenicol resistant; Cmr) and the challenge 
strains, pFD340-tetQ (tetracycline resistant; Tetr). At each time point, fresh fecal samples 
were collected, homogenized and serially diluted in PBS and plated on selective media 
for CFU per g of feces.  
 
Colon whole-mount immunofluorescence experiments.  
Colons were fixed in buffered 4% paraformaldehyde, washed with PBS and 
subjected to indirect immunofluorescence. Tissues were made permeable by incubation 
with 0.5% (wt/vol) saponin, 2% (vol/vol) FBS, and 0.09% (wt/vol) azide in PBS for at 
least 18 hours. The same buffer was used for subsequent incubations with antibodies. 
Colon fragments (2 mm x 2 mm) were incubated with a primary polyclonal chicken IgY 
anti-B. fragilis antibodies for 12–16 hours at room temperature followed by 1–2 hour 
incubation at 37°C. Following PBS washes, samples were reacted with goat anti-chicken 
IgY secondary antibodies (Alexa Fluor 488 or Alexa Fluor 633, 2 µg/ml, Molecular 
Probes), fluorescently labeled phalloidin (fluorescein or AF568, 2 U/ml, Molecular 
Probes) and DAPI (2 µg/ml, Molecular Probes). Tissues were mounted in Prolong Gold 
(Invitrogen) and allowed to cure for at least 48 hours prior to imaging. In some 
experiments, anti-B. fragilis antibodies were preabsorbed on tissue fragments (4 mm x 4 
mm) derived from germ-free mice for 18 hours at room temperature. 
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Fluorescence microscopy. 
An SP5 resonant laser-scanning confocal and two-photon microscope (both 
scanning heads mounted on the same DM 6000 upright microscope, Leica Microsystems) 
with a 40× oil objective (numerical aperture 1.4) or 63× oil objective (numerical aperture 
1.4) were used for fluorescence microscopy. Images used for 3D reconstructions were 
acquired using dual confocal – two photon mode. For confocal imaging, 488-nm and 
543-nm excitation wavelengths were used for Alexa Fluor 488-labeled bacteria and 
Alexa Fluor 568-labeled phalliodin, and signals were detected with internal 
photomultiplier tubes. 2-photon imaging was performed with 4 nondescanned detectors 
(Leica Microsystems) and a Chameleon Ultra Ti: Sapphire laser (Coherent) tuned at 700–
800 nm for acquisition. Emitted fluorescence was split with 3 dichroic mirrors (496 nm, 
560 nm and 593 nm) and passed through filter (Semrock) at 585/40 nm. Images 
(512x512) acquired with a 0.5 µm Z step were smoothed by median filtering at kernel 
size 3 × 3 pixels. 3D reconstructions of crypts and bacteria were performed using Imaris 
software (version 7.5.1 ×64; Bitplane AG). Crypt structures were visualized by DAPI and 
phalloidin signals. Images used for quantification were acquired with FluoView FV10i 
confocal microscope (Olympus) using 60x (NA 1.35) oil objective. Frames of 512x512 
pixels were acquired with 1 µm Z steps in the crypt length axis. Images were processed 
using ImageJ software (NIH). Background was subtracted (rolling ball method), images 
were smoothed by median filtering (3x3 pixels), images were segmented by threshold 
and position of the signal in the Z stack was recorded. Data did not follow normal 
distribution and were analyzed by non-parametrical two-sided Mann Whitney test. 
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SPF animal colonization experiments.  
7–8 week old male SPF mice (C57BL/6, Swiss Webster, NOD, and Rag-/-) were 
given a single inoculum of 108 CFU of either WT B. fragilis, B. fragilisΔCCF, or 1:1 
mixture of the two strains by oral gavage.  At each time point, bacterial genomic DNA 
from fecal samples were isolated using a commercial kit (ZR Fecal DNA MiniPrepTM, 
Zymo Research) following the manufacturer’s instructions and the relative densities of 
bacteria were determined by qPCR using strain-specific primers (Supplementary Table 
3.2).   
 
Antibiotic treatment.  
8–10 week old germ-free Swiss Webster mice were co-associated with WT B. 
fragilis (Cmr) and B. fragilisΔCCF (Tetr) mixed at 1:1 ratio for 1 week.  Animals were 
treated with ciprofloxacin for 5 days dissolved in drinking water (1 mg/ml; Hikma 
Pharmaceuticals).  Bacterial CFU of each strain was determined by plating on selective 
media.   
 
Citrobacter rodentium infection.  
8 week old female SPF Swiss Webster mice were treated with metronidazole (100 
mg/kg) by oral gavage every 24 hours and ciprofloxacin dissolved in drinking water 
(0.625 mg/ml) for seven days; mice were transferred to a fresh sterile cage every two 
days. Two days after the cessation of antibiotic treatment, mice were orally gavaged a 
single inoculum of 1:1 mixture of WT B. fragilis and B. fragilisΔCCF (~ 5x108 CFU total 
per animal).  6–7 days after B. fragilis gavage, mice were either infected orally with ~ 
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5x108 CFU of overnight culture C. rodentium or PBS-gavaged as control.  The relative 
densities of bacteria were determined by fecal bacterial DNA extraction and qPCR. 
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Supplementary Figure 3.1 | (A) Germ-free Swiss Webster mice are mono-associated 
with B. thetaiotaomicron containing pFD340-cat (chloramphenicol resistant) for 6 days 
and subsequently challenged orally with ~ 108 CFU of B. thetaiotaomicron containing 
pFD340-tetQ (tetracycline resistant). CFU is determined by homogenizing 
fresh feces in PBS and plating serial dilutions on BHIS agar plate with either 
chloramphenicol or tetracycline. Dashed line indicates the limit of detection at 100 
CFU/g feces (n=3 animals/group). (B) Germ-free Swiss Webster mice are mono-
associated with B. ovatus containing pFD340-cat (chloramphenicol resistant) for 9 days 
and subsequently challenged orally with ~ 108 CFU of B. ovatus containing pFD340-tetQ 
(tetracycline resistant). CFU is determined by homogenizing fresh feces in PBS and 
plating serial dilutions on BHIS agar plate with either chloramphenicol or tetracycline. 
Dashed line indicates the limit of detection at 100 CFU/g feces (n=3 animals/group). 
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Supplementary Figure 3.2 | (A) Germ-free Swiss Webster mice are mono-associated 
with E. coli JM109 containing pNJR6 (kanamycin resistant) for 6 days and subsequently 
challenged orally with ~ 108 CFU of E. coli JM109 containing pFD340 (ampicillin 
resistant). CFU is determined by serial dilution plating of fecal homogenate on LB agar 
plate with either ampicillin or kanamycin. (B) Germ-free Swiss Webster mice are mono-
associated with a capsular polysaccharide mutant B. fragilis strain (CPM1) containing 
pFD340 (Em-resistant, Cm-sensitive) for 11 days and subsequently challenged 
orally with ~ 108 CFU of wild-type B. fragilis containing pFD340-cat (Emr, Cmr). CFU is 
determined by serial dilution plating of fecal homogenate on BHIS plate with either Em 
or Cm. Dashed line indicates the limit of detection at 100 CFU/g feces. 
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Supplementary Figure 3.3 | (A) MicrobesOnline Operon Predictions. BF3581 was used 
as a query gene, shown in navy blue in the operon viewer.  Shown in light blue, BF3580 
and BF3579 are predicted to be in the same operon.  The arrowhead indicates the 
transcription direction.  The numbers below the genes indicate the intergenic distance 
between two adjacent genes.  (B) An operon (ID: 51407) was found in DOOR (Database 
of prOkaryotic OpeRons) by gene query using BF3581.  BF3580 and BF3579 also belong 
to the same operon.   
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Supplementary Figure 3.4 | Germ-free Swiss Webster mice were mono-associated with 
B. vulgatus (wild-type, mutant strains deleted in the putative structural ccf genes 
(BVΔCCF) or complemented with the ccfA-E genes from B. fragilis (B. vulg::BFCCF)) 
for 6–7 days and subsequently challenged orally with ~ 108 CFU of various challenge 
strains (B. vulgatus, BVΔCCF or B. fragilis).  CFU of the initial strains and the challenge 
strains were enumerated from feces by microbiological plating with antibiotic selection 
30 days after challenge.  Dashed line indicates the limit of detection at 100 CFU/g feces.  
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Supplementary Figure 3.5 | (A) qRT-PCR of the ccf gene expression levels from 
BFΔccfB mono-associated animal feces, cecal content and colon tissues (n=3 
animals/group) and culture. (B) Fecal bacterial colonization levels measured from germ-
free mice mono-associated with BFΔccfB and subsequently challenged with 108 CFU of 
WT B. fragilis. 
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Supplementary Figure 3.6 | B. fragilis colonization level as relative copy number was 
determined by fecal DNA qPCR for the following animal experiments: (A) SPF Swiss 
Webster mice were challenged with 108, 107, 106, or 105 CFU of B. fragilis by oral gavage. 
(B) Germ-free Swiss Webster mice were mono-associated with B. fragilis for 2 weeks and 
orally challenged with cecal content diluted in PBS from SPF Swiss Webster mice. (C) SPF 
C57BL/6 mice were challenged with 108 CFU of B. fragilis by oral gavage. (D) C57BL/6 
mice mono-associated with B. fragilis from birth were orally challenged with cecal content 
diluted in PBS from SPF C57BL/6 mice. 
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Supplementary Table 3.1 | Strains and plasmids used in this study. 
Strain or plasmid Description Reference 
or source 
E. cloni® 10G F- mcrA Δ(mrr-hsdRMS-mcrBC) endA1 recA1 
Φ80dlacZΔM15 ΔlacX74 araD139 Δ(ara,leu)7697 galU 
galK rpsL nupG λ- tonA; Standard cloning strain 
Lucigen 
E. coli JM109 F`[traD36 proA+B+ laclq ∆(lacZ)M15] ∆(lac-proAB) 
glnV44 (supE44) e14- (McrA-) thi gyrA96 (NalR) endA1 
hsdR17(rk- mk+) relA1 recA1; standard cloning strain 
Zymo 
Research 
Bacteroides fragilis 
NCTC 9343 
Type strain [1] 
B. fragilis 9343ΔPSA 
Δmpi.off (CPM1) 
B. fragilis 9343ΔPSA mutant with chromosomal deletion of 
534- of 591-bp in the mpi gene; invertible promoters for 
PSA, PSB, and PSD-H all in “off” orientation 
[2] 
B. fragilis 9343ΔccfA B. fragilis 9343 mutant with chromosomal deletion in ccfA 
gene (BF3583); 312 bp of the 579-bp ccfA gene removed 
This study 
B. fragilis 9343ΔccfB B. fragilis 9343 mutant with chromosomal deletion in ccfB 
gene (BF3582); 945 bp of the 1221-bp ccfB gene removed 
This study 
B. fragilis 9343ΔccfC B. fragilis 9343 mutant with chromosomal deletion in ccfC 
gene (BF3581); 2148 bp of the 3477-bp ccfC gene removed 
This study 
B. fragilis 9343ΔccfD B. fragilis 9343 mutant with chromosomal deletion in ccfD 
gene (BF3580); 1086 bp of the 1887-bp ccfD gene removed 
This study 
B. fragilis 9343ΔccfE B. fragilis 9343 mutant with chromosomal deletion in ccfE 
gene (BF3579); 1006 bp of the 1323-bp ccfE gene removed 
This study 
B. fragilis 
9343ΔccfC-E  (B. 
fragilisΔCCF) 
B. fragilis 9343 mutant with chromosomal deletion of CCF 
operon in biosynthesis genes ccfC-E (BF3581-79); 6059 bp 
removed 
This study 
B. vulgatus ATCC 
8482 
Type strain [3] 
B. vulgatusΔccfC-E 
(B. vulgatusΔCCF) 
B. vulgatus mutant with chromosomal deletion of CCF 
operon in biosynthesis genes ccfC-E (BVU946-8); 6304 bp 
removed 
This study 
B. vulgatus::BFCCF B. vulgatus complemented with B fragilis CCF operon.  
Clone S16 isolated from the in vivo chromosomal library 
screen.   
This study 
B. thetaiotaomicron 
ATCC 29148 
Type strain; VPI-5482 [4] 
B. ovatus ATCC 
8483 
Type strain [3] 
Citrobacter 
rodentium DBS100 
Type strain; ATCC 51459 [5] 
pNJR6 Bacteroides suicide vector; mob+ Tra- Kmr (E. coli) Emr 
(Bacteroides)  
[6]  
R751 Mobilizable mating plasmid to move constructs from E. coli 
to Bacteroides; Tra+ Tpr 
[7] 
RK231 Mobilizable mating plasmid to move constructs from E. coli 
to Bacteroides, RK2 derivative; Tra+ Tetr Kmr 
[8] 
pFD340 E. coli-Bacteroides shuttle vector, IS4351 promoter; Ampr (E. 
coli) Emr (Bacteroides)  
[9] 
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pFD340-cat Modified pFD340 plasmid containing cat gene PCR 
amplified from  
E. Coli K12/pACYC184 (accession #: X06403) cloned into a 
SmaI site; Ampr (E. coli) CmrEmr (Bacteroides) 
[2] 
pFD340-catBII E.coli-Bacteroides shuttle vector containing IS4351-cat 
cassette PCR amplified from pFD340-cat, BglII restriction 
site encoded at the 5’-end by PCR primer, and cloned into 
BamHI/PstI digested and blunted pFD340 backbone; Ampr 
(E. coli) CmrEmr (Bacteroides) 
This study 
pFD340-tetQ Modified pFD340 plasmid containing tetQ gene PCR 
amplified from Parabacteroides merdae ATCC 43184 cloned 
into BamHI/KpnI site; Ampr (E. coli) TetrEmr (Bacteroides) 
This study 
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Bacteroides-Ovatus, Bacteroides-Distasonis, Bacteroides-Thetaiotaomicron, and 
Bacteroides-Vulgatus—Designation of Neotype Strains for Bacteroides-Fragilis (Veillon 
and Zuber) Castellani and Chalmers and Bacteroides-Thetaiotaomicron (Distaso) 
Castellani and Chalmers. International Journal of Systematic Bacteriology, 1976. 26(2): 
230–237. 
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Supplementary Table 3.2 | Sequences of primers used for PCR in this study.  
Primers used for cloning recombinant genes and generating deletion constructs (bold: 5’ 
addition) 
Primer name Sequence Purpose 
IS4351-F2 AAAGATCTGAAAGAGAGACAATGTCCCC clone IS4351-cat  
cat2-X AACTCGAGCGAATTTCTGCCATTCATCCG clone IS4351-cat  
tetQ-F2 AAGGATCCGTAATCGTTATGCGGCAGTAATAATA
TACA 
clone tetQ 
tetQ-R AAGGTACCGAGCTCGTCTATTTTTTTATTGCCAAG clone tetQ 
delBF3583L_F CTGTCGACCGAGGGAAGCATCACTTCAT delete ccfA – left flank 
delBF3583L_R TTCCCGGTATTCTCCCAGACAGCGAGAGAT delete ccfA – left flank 
delBF3583R_F GTCTGGGAGAATACCGGGAATATAGCCATGC delete ccfA – right flank 
delBF3583R_R ATGTCGACTTGTGATACGTCCGTCGGTA delete ccfA – right flank 
delBF3582L_F AAGGATCCCGCACTGTTTTTGGGATCTT delete ccfB – left flank 
delBF3582L_R ATGGCCCGACGAGACGATTTACGGGATGT delete ccfB – left flank 
delBF3582R_F AATCGTCTCGTCGGGCCATACGTAATTCTC delete ccfB – right flank 
delBF3582R_R TTGGATCCTCCGATCCCTTTTGTTTGAG delete ccfB – right flank 
delBF3581L_F GTGGATCCTAGTTAAACTGACCGAACGATTGA delete ccfC – left flank 
delBF3581L_R TGCCATTACTTTTACCCGGAATAAAATTCTTGA delete ccfC – left flank 
delBF3581R_F CGGGTAAAAGTAATGGCACCTATGGTAGGATTC delete ccfC – right flank 
delBF3581R_R TTGGATCCTGTGAATGTTTATAGGCAGAAGGA delete ccfC – right flank 
delBF3580L_F GTGGATCCGGCTGATTTTATCAGAGTTCCTGT delete ccfD – left flank 
delBF3580L_R TCGTCAGGCTATTATTTTCCGTTTGGCAGATTT delete ccfD – left flank 
delBF3580R_F AAAATAATAGCCTGACGAATGTATTTGTAACAG delete ccfD – right flank 
delBF3580R_R TTGGATCCACTGTAGGGGTAGATCTCGCTATG delete ccfD – right flank 
delBF3579L_F AAGGATCCTTGGCATATCCGGAATTCAT delete ccfE – left flank 
delBF3579L_R TAGGCGAAAAGCGATCGGTCAGTTTGGTTTT delete ccfE – left flank 
delBF3579R_F TGACCGATCGCTTTTCGCCTACATTATAAGATTGC delete ccfE – right flank 
delBF3579R_R ATGGATCCGCGTCGACCAGTCCAATTAT delete ccfE – right flank 
delBF3579L_F AAGGATCCTTGGCATATCCGGAATTCAT delete ccfC-E – left flank 
delBF3579L_Rb TGCCATTACCGATCGGTCAGTTTGGTTTT delete ccfC-E – left flank 
delBF3581R_Fb TGACCGATCGGTAATGGCACCTATGGTAGGATTC delete ccfC-E – right flank 
delBF3581R_R TTGGATCCTGTGAATGTTTATAGGCAGAAGGA delete ccfC-E – right flank 
delBVU946L_F CTGTCGACGGATTTCGTCTTGCACAGGT delete ccfC-E – left flank 
(B. vulgatus) 
delBVU946L_R TGGGGAATCCACGTTGCTGCCCTCAAATAC delete ccfC-E – left flank 
(B. vulgatus) 
delBVU948R_F GCAGCAACGTGGATTCCCCACTGCTACAAA delete ccfC-E – right flank 
(B. vulgatus) 
delBVU948R_R ATGTCGACTCGACTCCGTAGATCCCATC delete ccfC-E – right flank 
(B. vulgatus) 
 
Primers used for quantitative PCR 
Primer name Sequence Target Reference 
or source 
BF3583 QF GGAATTTGCATGACACTTAT B. fragilis ccfA  This study 
BF3583 QR CTGAGAGGTTTCATCTTCTG B. fragilis ccfA  This study 
BF3582 QF AGTGTCCCCACTTCATCGTC B. fragilis ccfB This study 
BF3582 QR TGAAACTTTTGCCGGAGAAT B. fragilis ccfB  This study 
BF3581 QF GATGAACTGATAGCCCATTA B. fragilis ccfC  This study 
BF3581 QR TAGCGATGACTAAAGGTGTT B. fragilis ccfC  This study 
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BF3580 QF CGGTTATATGCTTTTCAAAC B. fragilis ccfD  This study 
BF3580 QR CAAATAGAAATCTGCCAAAC B. fragilis ccfD This study 
BF3579 QF TGCTATTTGCACGGGTAACA B. fragilis ccfE  This study 
BF3579 QR CCGAAACTCCGATTCTTCAT B. fragilis ccfE  This study 
Bfragilis 16S F TGATTCCGCATGGTTTCATT B. fragilis 16S rRNA  [10] 
Bfragilis 16S R CGACCCATAGAGCCTTCATC B. fragilis 16S rRNA [10] 
BF3581 QF3 CACCGATACCCTGCGTAAAT WT B. fragilis specific  This study 
BF3581 QR3 GGCGGACTGGTAACGATAAA WT B. fragilis specific  This study 
delCCF QF CGGTGCTAACGTTGTCGTAA B. fragilisΔCCF specific  This study 
delCCF QR ATTTTAGTGCGGCATCCTGA B. fragilisΔCCF specific  This study 
CfcH QF GGTAAATCCACCACCCTGAA C. rodentium specific  This study 
CfcH QR GTATTCCACGGGGTCTTCAA C. rodentium specific  This study 
UniF334 ACTCCTACGGGAGGCAGCAGT Universal 16S [11] 
UniR514 ATTACCGCGGCTGCTGGC Universal 16S [11] 
 
 
10. Odamaki, T., et al., Distribution of different species of the Bacteroides fragilis group in 
individuals with Japanese cedar pollinosis. Appl Environ Microbiol, 2008. 74(21):  
6814–6817. 
11. Amann, R.I., et al., Combination of 16S rRNA-targeted oligonucleotide probes with flow 
cytometry for analyzing mixed microbial populations. Appl Environ Microbiol, 1990. 
56(6): 1919–1925. 
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Chapter 4: 
 
Conclusions and future directions 
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B. fragilis capsular polysaccharides mediate gut colonization   
In Chapter 2, we showed that expression of at least one of eight capsular 
polysaccharides is critical for in vitro growth of B. fragilis and an attempt to abrogate 
expression of all capsular polysaccharides leads to spontaneous phenotypic reversion of 
the bacteria to express one of the polysaccharides, PSB, through promoter inversion. 
Clearly, B. fragilis invested a great deal of evolutionary energy into expressing multiple 
polysaccharides as part of its surface architecture and the ability to vary its capsule sugar 
molecules gives the organism advantage in establishing colonization in the host gut. We 
speculated that this dynamic and diverse surface sugar repertoire is important for long-
term and stable host colonization by B. fragilis.   
There are many possible explanations for why WT strain outcompetes CPM1 
strain (PSC-only expressing strain) during colonization. The ability to vary its capsular 
polysaccharide molecules may be important for camouflaging its surface and evading 
immune response when the bacteria is in intimate contact with the host cells.  Different 
polysaccharides may be required for surviving and transiting through different 
microenvironments within the gut.  Introducing heterogeneity within the B. fragilis 
population may increase their fitness in vivo.  Or, there may be a dominant 
polysaccharide out of the eight known molecules that is responsible for direct interaction 
with the host mediating stable colonization and it is missing from the CPM1 strain.  To 
address these questions, we can generate a variety of mutant strains expressing a single 
capsular polysaccharide (PSA-only, PSB-only, etc.) and test their colonization fitness in 
competition.  If there were indeed a dominant polysaccharide molecule directly 
responsible for colonization, this approach would reveal the identity of the molecule and 
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open doors to further dissection of colonization mechanism of a model symbiont.  Similar 
mutants can be generated using other Bacteroides species that express phase-variable 
multiple capsular polysaccharides (Coyne and Comstock, 2008) to show conservation of 
the mechanism among other gut symbionts of this genus.   
 
Species-specific and saturable gut colonization by Bacteroides  
 In Chapter 3, we discovered that many of the intestinal Bacteroides species 
colonize the host gut by saturation of a limited niche which is a previously unknown 
phenomenon and unique to the Bacteroides genus (although we have only tested E. coli 
JM109 as a control). Remarkably, B. fragilis mono-associated mice resisted additional 
colonization by the isogenic B. fragilis strain and the same was observed in B. 
thetaiotaomicron, B. ovatus and B. vulgatus.  Different Bacteroides species, however, 
were able to both colonize the same animal.  From these observations, we concluded that 
Bacteroides species occupy limited and saturable niche in the gut that is specific to the 
species and different species do not compete for the same niche.  To our knowledge, it is 
the first time such an observation has been made with regards to commensal microbe and 
host interaction.   
This finding opens up many additional questions and future studies.  Bacteroides 
is one of many major bacterial genera that make up the mammalian gut microbiota 
(Eckburg et al., 2005) and it would be important to assess if the other groups such as 
Clostridium, Lactobacillus, Bifidobacterium, and E. coli also establish long-term 
colonization by occupying saturable, species-specific niche using gnotobiotic animal 
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model.  Consequently, we will learn whether this mechanism is universal to a broader 
range of commensal organisms or if it is unique to the Bacteroides genus.   
The colonization studies strongly implicate presence of distinct species-specific 
niches in the intestine for Bacteroides. Visualization of the Bacteroides biogeography 
within the host intestine can be accomplished by immunofluorescence or fluorescence in 
situ hybridization techniques by developing probes that specifically recognize different 
species. This approach will elucidate whether Bacteroides species segregate spatially 
within the intestine or occupy distinct niches through an entirely different mechanism 
(i.e., nutrient or host receptor binding), which will subsequently provide insight into 
which host-derived factors may serve as nutrient substrates or docking sites for specific 
microbes and regulate gut microbial community composition.  
 
Identification of a Sus-like system mediating Bacteroides colonization  
 In Chapter 3, we identified a novel molecular mechanism mediated by a set of 
genes in an operon which we named the commensal colonization factors (ccf).  By 
sequence homology, the CCF system is conserved among many Bacteroides species, 
many of which display saturable colonization phenotype, and at the core of the operon is 
the SucC/D family of proteins, one of the largest cohort of outer membrane protein 
complexes conserved among the Bacteroidetes that bind and import a wide range of 
polysaccharides (Kuwahara et al., 2004; Cerdeno-Tarraga et al., 2005; Schauer et al., 
2008; Martens et al., 2009).  
The starch utilization system (Sus) has been extensively studied from B. 
thetaiotaomicron (Koropatkin et al., 2012). Whole-genome transcriptional profiling of B. 
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thetaiotaomicron disclosed that the bacteria expresses different sets of carbohydrate 
utilization genes (37 SusC and 16 SusD paralogs were up-regulated) when introduced 
into the germ-free mouse gut compared to when grown in broth consisting of minimal 
medium with glucose (MM-G) (Sonnenburg et al., 2005).  The glycan foraging behavior 
of the gut symbiont was further explored by comparing the bacterial gene expressions in 
germ-free mice maintained either on the standard polysaccharide-rich chow diet or on the 
simple sugar diet devoid of fermentable polysaccharide.  Whereas the polysaccharide-
rich diet induced up-regulation of carbohydrate utilization genes such as xylanases, 
arabinosidases, and pectate lyases, glucose and sucrose only diet led to increased 
expression of a different subset of genes involved in retrieving carbohydrates from mucus 
glycans such as hexosaminidases, α-fucosidases and a sialidase. These genes may also 
serve to mediate bacterial attachment to mucus glycan to avoid bacterial washout from 
the gut (Xu et al., 2003; Xu and Gordon, 2003). The ability to salvage energy from 
nutrients that are otherwise non-digestible by the host provides an evolutionary driving 
force for the bacteria to maintain residency in the host intestine.  
The CCF system reveals a novel, evolutionarily conserved molecular pathway by 
which prominent human Bacteroides species maintain persistent colonization of the 
mammalian gut. Homology to the Sus family of proteins suggests that the putative outer 
membrane complex we have identified is involved in uptake and utilization of glycans. 
Our discovery of saturable colonization within, but not between, species suggests that 
individual Bacteroides members utilize unique and limiting sugars for association with 
the host. We have identified a conserved clade of the sus genes, and our data suggest a 
model that (at least a subset of) Sus systems evolved to sense and utilize limiting glycan 
  106 
nutrients by individual Bacteroides species to promote intestinal colonization and 
identification of the chemical substrate(s) for the CCF system will serve as a crucial 
future direction.   
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a b s t r a c t
The mammalian gastrointestinal tract harbors a vast microbial ecosystem, known as the microbiota,
which benefits host biology. Bacteroides fragilis is an important anaerobic gut commensal of humans that
prevents and cures intestinal inflammation. We wished to elucidate aspects of gut colonization employed
by B. fragilis. Fluorescence in situ hybridization was performed on colonic tissue sections from B. fragilis
and Escherichia coli dual-colonized gnotobiotic mice. Epifluorescence imaging reveals that both E. coli and
B. fragilis are found in the lumen of the colon, but only B. fragilis is found in the mucosal layer. This
observation suggests that physical association with intestinal mucus could be a possible mechanism of
gut colonization by B. fragilis. We investigated this potential interaction using an in vitro mucus binding
assay and show here that B. fragilis binds to murine colonic mucus. We further demonstrate that B. fragilis
specifically and quantitatively binds to highly purified mucins (the major constituent in intestinal mucus)
using flow cytometry analysis of fluorescently labeled purified murine and porcine mucins. These results
suggest that interactions between B. fragilis and intestinal mucin may play a critical role during host-
bacterial symbiosis.
! 2011 Elsevier Ltd. All rights reserved.
Following a sterile birth, the gastrointestinal (GI) tracts of
humans and all mammals coordinately assemble a diverse multi-
tude ofmicroorganisms, collectively known as themicrobiota. It has
been acknowledged for decades thatmany of thesemicroorganisms
live symbiotically with their hosts, performing beneficial functions
such as metabolizing complex carbohydrates and providing essen-
tial nutrients [1]. Recent studies have shown that the microbiota
critically augments the development and function of the immune
system (reviewed in [2] and [3]). Although themicrobial diversity in
the mammalian gut is vast (with an estimated 500e1000 species of
microorganisms present in the human), organisms belonging to the
genus Bacteroides represent one of the most abundant microbial
taxa in bothmice and humans [4]. Bacteroides fragilis is a ubiquitous
Gram-negative anaerobic bacterium that inhabits the lower GI tract
of most mammals [5]. Recent findings have revealed that this
organism possesses the ability to direct the cellular and physical
maturation of the host immune system and to protect its host from
experimental colitis [6e8]. Therefore, the contributions of the
microbiota to human health appear to be profound.
Wewanted tounderstandhowB. fragiliscolonizes themammalian
gut. B. fragilis expresses at least eight distinct surface capsular
polysaccharides (CPS), and previous studies have shown that CPS
expression by the bacterium is required for successful intestinal
colonization [9,10]. How these molecules mediate the initial inter-
actions with the host, and whether they are involved in long-term
persistence in the gut are currently unknown. Several mechanisms
of gut colonization by symbiotic bacteria have been studied. Some
organisms formbiofilms, composedofapolymericmatrix secretedby
the bacteria,which adhere to the epithelial layer. Others interactwith
components of the mucosal layer (reviewed in [11]). Mucus is
a viscous stratumwhich separates epithelial cells from the lumen of
the gut and acts as a crucial barrier against infection by pathogens.
Various membrane-bound or secreted glycoproteins called mucins
associate with one another to form the gel-like mucus. Interactions
between gut bacteria and mucus have been hypothesized to be
important for the assembly and stability of the microbiota [12].
Accordingly, we sought to determine whether or not B. fragilis binds
intestinal mucus and purified mucin.
Initially, we visualized the spatial localization in the colon of
2 different commensal bacteria to determine potential differences
in association with the mucus layer in vivo. Wild-type B. fragilis
NCTC9343 was grown anaerobically in brain-heart infusion (BHI)
supplemented with hemin (5 mg/ml) and vitamin K (0.5 mg/ml), and
Escherichia coli BL21 was grown aerobically in BHI at 37 !C. Bacteria
were grown to OD600 of 0.7e0.8, and 1 " 108 colony forming units
(CFUs) were orally inoculated into germ-free Swiss Webster mice
by gavage. Following 1 week of colonization, mice were sacrificed
and colon tissue was fixed in Carnoy’s solution and embedded in
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paraffin wax for sectioning. Fluorescence in situ hybridization was
performed on tissue sections mounted on glass slides using a 6-
carboxyfluorescein (6-FAM)-labeled oligonucleotide probe for E.
coli (EnterbactB [AAGCCACGCCTCAAGGGCACAA]) and a Cy3-
labeled oligonucleotide probe for B. fragilis (Bfra602 [GAGCCG-
CAAACTTTCACAA]) (Integrated DNA Technologies, Inc.). Briefly,
slides were deparaffinized, dried, and hybridized with both probes
at 5 ng/ml concentration each for 2 h at 46 !C in hybridization buffer
(0.9 M NaCl, 15% formamide, 20 mM TriseHCl (pH 7.4), and 0.01%
sodium dodecyl sulfate (SDS)). Slides were washed for 15 min at
48 !C in wash buffer (20 mM TriseHCl (pH 7.4), 318 mM NaCl, and
0.01% SDS). For visualization of the colon epithelial cell nuclei, the
slides were counterstained with 40,60-diamidino-2-phenylindole
(DAPI). The autofluorescence background allowed visualization of
the tissue structures. The slides were examined with an Axioplan
microscope (Zeiss, Oberkochen, Germany) using a 100" oil
immersion objective. Epifluorescence images of a cross section
through the colon of gnotobiotic mice that were dual-colonized
with both E. coli and B. fragilis reveal that both bacteria are found
in the lumen of the gut in high abundance (Fig. 1). Surprisingly
however, only B. fragilis is found in the mucus layer that lies
between the lumen and the gut epithelium tissue (Fig. 1). The
spatial segregation of B. fragilis and E. coli across the colon mucus
barrier suggests that B. fragilismay interact with mucus in vivo and
this may be important for sustained colonization of commensal B.
fragilis. Furthermore, these results reveal that not all bacteria are
equally able to penetrate the mucus layer, suggesting dedicated
mucus associating functions for B. fragilis.
To test the hypothesis that B. fragilis colonization of the distal
gut is mediated by mucus binding, a standard mucus binding assay
was used to determine if live bacteria are able to bind a crude,
intestinal mucus preparation. Crude mucus was isolated from the
colon and cecum of conventionally-colonized Swiss Webster mice
as described in Cohen et al. [13]. Briefly, colonic and cecal mucus
was scraped into HEPES-Hanks’ Buffer (pH 7.4 with Calcium Chlo-
ride and Magnesium Chloride). Next, non-soluble material was
removed by centrifuging once at 12,000 " g for 10 min at 4 !C, and
then once at 26,500 " g for 15 min at 4 !C. The final concentration
of the crude mucus solutionwas determined by the Bradford assay.
The mucus was diluted with HEPES-Hanks’ Buffer to 1 mg/ml.
0.2 ml of mucus was added into the wells of a 24-well tissue culture
plate and incubated overnight at 4 !C. Controls included wells
containing 0.2 ml of a 1 mg/ml solution of Bovine Serum Albumin
(BSA, which served as a specificity control) or 0.2 ml of HEPES-
Hanks’ Buffer (which served as a negative control). The wells were
washed with HEPES-Hanks’ Buffer to remove non-immobilized
proteins. The plate was UV-sterilized for 10 min and was then
ready for use in the mucus binding assay. 1 " 108 CFUs of bacteria
were added to both the immobilized mucus and the BSA control,
and incubated at 37 !C for 1 h. Wells were washed with HEPES-
Hanks’ Buffer, treated with 0.05% trypsin for 10 min at room
temperature to liberate bacteria. One milliliter of cold BHI was
added to quench the trypsin activity. Samples were serially diluted
and plated for CFUs. Fig. 2A shows that B. fragilis binds to crudely
purified mucus in vitro, as determined by recovered CFUs. The BSA-
and buffer-containing wells illustrate low background binding. A
mutant strain of B. fragilis (CPM1), which only expresses one of the
eight CPS [9], is able to bind mucus as effectively as wild-type B.
fragilis, suggesting that CPS expression does not mediate mucus
binding. Therefore, B. fragilis specifically binds intestinal mucus via
a mechanism that appears not to involve expression of multiple
surface polysaccharides.
Next, a mucus binding competition assay was performed to
determine if the interaction between B. fragilis and mucus is satu-
rable. We reasoned that as B. fragilis is pre-coated with higher
concentrations of excess mucus, fewer putative receptors would be
available to bind immobilizedmucus in thewell. Briefly,1"108 CFUs
of B. fragiliswere incubated with excess mucus at 37 !C for 2 h under
aerobic conditions with shaking. Bacteriawere washed and added to
Fig. 1. Colon tissue section from a B. fragilis and E. coli dual-colonized Swiss Webster
mouse. Epifluorescence image of bacteria visualized by FISH, and the epithelial cells
counterstained with DAPI (blue) to visualize DNA. Both E. coli (green) and B. fragilis
(red) are found in the lumen but only B. fragilis is found in the mucus layer. (For
interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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Fig. 2. B. fragilis binds intestinal mucus. (A) Number of B. fragilis (in CFUs) recovered
after 1 h incubation in wells with an immobilized mucus layer, an immobilized BSA
layer, or buffer only. Of the 1 " 108 CFUs incubated, 1.6 " 106 (1.6%) bound to immo-
bilized mucus. The CPM1 mutant binds mucus similarly to wild-type bacteria. These
data are representative of four independent trials. (B) Number of bacteria recovered
from mucus binding assay after a 2 h pre-incubation with different concentrations of
excess mucus. These data are representative of three independent trials.
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wells of a 24-well tissue culture plate containing either immobilized
mucus, BSA, or nothing (prepared as above). After 1 h, samples were
treated with trypsin, serially diluted, and plated for CFUs. Unex-
pectedly, pre-incubation with excess mucus appeared to increase B.
fragilis binding to mucus with a bi-phasing profile (Fig. 2B). Binding
to immobilized mucus reached a peak when B. fragilis was pre-
incubated with 0.2 mg/ml of excess mucus. Pre-incubation of
bacteria with excess mucus at concentrations higher than 0.2 mg/ml
resulted in a decrease in mucus binding, yet binding was still higher
thanwithout pre-incubation with mucus. Pre-incubation of bacteria
with 0.4 mg/ml and 1 mg/ml of BSA did not affect binding, once
again showing that the B. fragilis-mucus interaction is specific (data
not shown). These results suggest that bacteria pre-incubated with
mucus (and not BSA) have an increased ability to bind immobilized
mucus until putative receptors are saturated at the highest mucus
concentrations. Further experiments are required to determine if
dedicated molecules on the bacterial surface mediate mucus
binding.
In addition to mucin, intestinal mucus is known to contain host
molecules, such as anti-microbial peptides, immunoglobulin A
(IgA) antibodies, and lysozyme [13]. We wished to determine if
mucus binding by B. fragilis was specific to mucin. As murine
colonic mucin is not commercially available, we purified mucins
from Swiss Webster mice based on the protocol by Shekels et al.
[14] with a few modifications. Fig. 3 illustrates a schematic of this
modified protocol and the analysis of mucin purity. We then tested
the purified mucin and BSA for specific binding by B. fragilis. Puri-
fiedmucin and the BSA control were labeled with Thermo Scientific
DyLight Amine-Reactive Fluor 488, and unbound fluorophores
were removed from the sample via dialysis against PBS. B. fragilis
was pre-incubated with either unlabeled BSA or PBS and was
subsequently incubated with labeled mucin or labeled BSA for
30 min at room temperature. The bacteria were washed after each
incubation to remove non-adherent material. Percentage of mucin-
binding bacteria in each samplewas determined by flow cytometry.
When B. fragilis was incubated with fluorescently labeled BSA, no
binding was detected (Fig. 4A). However, when B. fragilis was
incubatedwith labeledmucin, a significant number of B. fragiliswas
detected by flow cytometry. Pre-incubation with BSA did not
diminish the percentage of B. fragilis adherent to mucin (Fig. 4A).
Taken together, B. fragilis binds specifically to purified murine
colonic mucin and not to BSA.
B. fragilis colonizes the intestines of most mammalian species
studied to date [5]. In order to determine ifmucin interactions extend
beyond themurine host, we examined the ability ofB. fragilis to bind
porcine mucin. Starting with partially purified porcine gastric mucin
purchased from Sigma Aldrich, we purified mucin to homogeneity
using the same protocol as described above. Fig. 4B shows that
a significant amountofmucin-bindingbacteriaweredetectedbyflow
cytometry, indicating that B. fragilis bound the fluorescently labeled
purified porcine mucin. Both approaches we used in this study to
demonstrate mucus binding resulted in only a small portion of
Mucin Purification
Adaptation of Protocol by Shekels et al. 1995
Scrap colonic mucus into 0.1 M NH4 HCO3,
0.5 M NaCl, protease inhibitor Dialyze against water
Homogenize sample
Centrifuge at 45,000 x g for 
Lyophilization
Perform glycoprotein 
stain on CsCl 
fractions using Pro Q 
Emerald 300
45 min
Centrifuge at 45,000 x g for 
Digest with RNase A and 
DNase I for 2 hours @ 
room temp
Lipopolysaccharide
(and Glycoprotein) 
Gel stain Kit
Take supernatant
Pool45 min
Dialyze against 10 mM Tris 
+ 150 mM NaCl, pH 8
Centrifuge at 27,000 x g 
for 30 min
Dialyze against
Take supernatant fractions
Dialyze against PBS
water
Lyophilization
Take supernatant
Sonicate sample: 8, 15-sec 
pulses with intermediate1 min 
Size fractionate protein on XK 26 
Sephacryl S-400 HR resin
12 ml CsCl gradient @ concentration 
of 0.54 g/ml (72 hours at 160,000 x g)
cooling on ice
Fig. 3. Schematic of the mucin purification protocol. Briefly, crude mucus was scraped from the colon and cecum of conventionally-colonized 8-week-old male Swiss Webster mice
into 0.1 M NH4HCO3, 0.5 M NaCl, and a cocktail of protease inhibitors on ice. The sample was then homogenized and centrifuged at 45,000 ! g for 45 min at 4 "C. Non-soluble
material was removed before centrifuging again at 45,000 ! g for another 45 min at 4 "C. The supernatant was taken and dialyzed against 10 mM Tris pH 8.0 þ 150 mM NaCl
for about 24 h. Next, the sample was sonicated at eight 15-s pulses with intermediate 1 min cooling on ice on a Brason Sonicator at speed 3 to break up large aggregates and then
centrifuged once more at 45,000 ! g for 45 min. Next HPLC was employed whereby the supernatant was size fractionated on an XK 26/70 column containing Sephacryl S-400 resin
(equilibrated in 10 mM Tris, pH 8.0). The void volume (which contained the large mucin glycoproteins) was collected and dialyzed against water for about 36 h and then lyophilized.
The lyophilized glycoproteins were resuspended in a solution containing RNase A and DNase I and digested for 2 h at room temperature. After the digestion, the sample was
centrifuged at 27,000 ! g for 30 min at 4 "C and the supernatant was dialyzed against phosphate buffered saline (PBS) for 36 h. Cesium chloride was added to the dialyzed
supernatant to a final concentration of 0.54 g/ml, and then centrifuged at 160,000 ! g for 72 h. One milliliter fractions were collected and analyzed with the Pro Q Emerald
Glycoprotein Staining Kit to determine which fractions contained the purified mucins. The mucin-containing fractions were pooled, dialyzed against water for 24 h, lyophilized, and
then stored at $20 "C. Positive fractions from gel filtration chromatography were identified by absorbance readings at 280 nm. CsCl fractions and final product were assayed to
contain mucin by glycoprotein staining (data not shown).
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bacterial binding (w1.6% for the immobilized plate assay andw1.5%
for the soluble mucin binding assay). This is consistent with the
known ability of B. fragilis to be highly phase variable whereby only
a portion of the bacterial population express a given surfacemolecule
[15]. Fig. 4C shows that pre-incubation with 1.0 mg/ml of unlabeled
mucin was able to compete with the fluorescently-labeled mucin,
resulting in a lower percentage of bacteria binding to the fluo-
rescently labeled mucin. Pre-incubation with BSA shows no inhibi-
tion (Fig. 4C), serving as a specificity control. Our results show that B.
fragilis specifically binds porcinemucin in addition to murinemucin.
B. fragilis has emerged as a model symbiont for the study of
hostemicrobial interactions with the immune system [3]. The
mechanism by which B. fragilis maintains long-term colonization of
the mammalian intestine remains unknown. Associations with
mucus may involve bacterial binding, and/or nutrient utilization of
mucin for bacterial growth. If binding tomucus is involvedduring the
colonization process in vivo, we predict that B. fragiliswould express
defined and dedicated receptor(s) with specific affinity for mucin.
Along these lines, the B. fragilis genome and other sequenced Bac-
teroides species express numerous homologs of the SusC/SusD
proteins, which are known to bind starch and other carbohydrates
that decorate the mucin glycoproteins [16]. Furthermore, SusC/SusD
proteins of B. fragilis were recently shown to be phase variable [17].
This property is similar to the phase variability of capsular poly-
saccharides,wherebyonlya small fractionof bacteria express anyone
of theeightCPSofB. fragilis [9]. Ifmucusbinding is alsophasevariable,
thiswould explainwhyonly a small percentage of bacteria invade the
mucus layer (as shown in Fig. 1), and why only a small fraction of
bacteria bindmucus andmucin in vitro (as shown in Figs. 2 and 4). A
non-mutually exclusive function formucus bindingmay be the use of
host derived sugars as a carbon source. Several studies have shown
that B. fragilis can degrademucin and utilize it as a nutrient source for
growth [18,19]. In fact, B. fragilis can utilize porcine mucin as a sole
source for carbon and nitrogen [20], and structural analysis of the
SusD homolog of Bacteroides thetaiotaomicron (also found in B. fra-
gilis) suggests it binds sugars liberated frommucinglycoproteins[21].
Therefore, mucus binding may serve as a physical mechanism for
sustained colonization, as a means to degrade and import nutrients
into the bacterial cell for growth, or both.We have shownhere thatB.
fragilis specificallybinds intestinalmucin (althoughB. fragilismayalso
bind to other components in the mucus) and associates with the
mucus layer invivo. Thesefindings, alongwithpreviouswork, suggest
that specific interactions between B. fragilis and mucus are relevant
for in vivo colonization of animals. The identity of dedicated mucin-
binding receptor(s), and a molecular mechanism during long-term
association of the mammalian gut, await discovery.
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The Toll-Like Receptor 2 Pathway
Establishes Colonization by a
Commensal of the Human Microbiota
June L. Round,1* S. Melanie Lee,1 Jennifer Li,1 Gloria Tran,1 Bana Jabri,2
Talal A. Chatila,3 Sarkis K. Mazmanian1*
Mucosal surfaces constantly encounter microbes. Toll-like receptors (TLRs) mediate recognition
of microbial patterns to eliminate pathogens. By contrast, we demonstrate that the prominent
gut commensal Bacteroides fragilis activates the TLR pathway to establish host-microbial symbiosis.
TLR2 on CD4+ T cells is required for B. fragilis colonization of a unique mucosal niche in mice
during homeostasis. A symbiosis factor (PSA, polysaccharide A) of B. fragilis signals through
TLR2 directly on Foxp3+ regulatory T cells to promote immunologic tolerance. B. fragilis lacking
PSA is unable to restrain T helper 17 cell responses and is defective in niche-specific mucosal
colonization. Therefore, commensal bacteria exploit the TLR pathway to actively suppress
immunity. We propose that the immune system can discriminate between pathogens and the
microbiota through recognition of symbiotic bacterial molecules in a process that engenders
commensal colonization.
Throughout our lives, we continuously en-counter microorganisms that range fromthose essential for health to those causing
death (1). Consequently, our immune system is
charged with the critical task of distinguishing
between beneficial and pathogenic microbes.
Toll-like receptors (TLRs) are evolutionarily con-
served molecules that promote immune responses,
and TLR signaling by innate immune cells is in-
dispensable for proper activation of the immune
system during infections. T cells also express func-
tional TLRs (2–4), and TLR signaling has further-
more been shown to restrain immune responses
(5). As symbionts and pathogens produce sim-
ilar molecular patterns that are sensed by TLRs,
the mechanisms by which our immune system
differentiates between the microbiota and enteric
infections remain unknown.
Whereas the intestinal microbiota contains
hundreds of bacterial species and is integral to
human health (6), the mucosal immune system
employs an arsenal of responses to control en-
teric pathogens. Germ-free mice lack proinflam-
matory T helper 17 (TH17) cells in the gut (7, 8)
(Fig. 1A), and only select symbiotic bacteria can
induce TH17 cells (9, 10). Most microbes express
common TLR ligands (e.g., peptidoglycan, unmeth-
ylated CpG, and lipoproteins); therefore, how do
symbionts avoid triggering intestinal immunity in
their mammalian hosts? We examined the hypoth-
esis that the human gut commensal Bacteroides
fragilis evolved molecular mechanisms to sup-
press TH17 responses during homeostatic colo-
nization. As predicted previously (7, 10, 11), we
found that B. fragilis mono-associated animals
did not induce TH17 cell development in the
colon compared to germ-free controls (Fig. 1A).
The beneficial contributions of B. fragilis require
a single immunomodulatory molecule named
polysaccharide A (PSA), which prevents and cures
inflammatory disease (12–14). Colonization with
B. fragilis in the absence of PSA (B. fragilisDPSA),
however, resulted in significant TH17 cell re-
sponses in the gut (Fig. 1, A and B). Colonic lam-
ina propria (LP) lymphocytes fromB. fragilisDPSA
mono-associated animals displayed increased se-
cretion of interleukin-17A (IL-17A) in vitro (fig.
S1) and elevated transcription of Il17a and the
TH17-specific lineage differentiation factor RORgt
(Rorc) (Fig. 1, C and D) (15). Differences in TH1
responses were not observed duringB. fragilisDPSA
colonization (fig. S2). Cells fromB. fragilismono-
associated animals produced low amounts of
IL-17A during in vitro TH17 skewing assays,
whereas CD4+ T cells from B. fragilisDPSA ani-
mals display elevated IL-17A production (fig. S3).
Administration of purified PSA toB. fragilisDPSA
mono-associated animals suppresses TH17 im-
munity (Fig. 1E). Thus, B. fragilis actively re-
strains TH17 cell responses during colonization.
Recent studies have shown that certain gut
bacteria can promote regulatory T cell (Treg) in-
duction (11, 14). Tregs expressing the transcrip-
tion factor Foxp3 (forkhead box P3) suppress
proinflammatory TH17 cell reactions. To test
whether Tregs prevent immune responses during
B. fragilis colonization, we reconstituted germ-
free Rag1−/− mice with bone marrow from Foxp3-
DTR (diphtheria toxin receptor) donors, which
allowed for specific ablation of Tregs by admin-
istration of diphtheria toxin (DT) (16). Mice
were mono-associated with B. fragilis to induce
Treg development (Fig. 1F). DT treatment of mice
resulted in depletion of Foxp3+ T cells (Fig. 1F),
with a concomitant increase in TH17 responses
(Fig. 1G and fig. S4), which suggests that Foxp3+
Tregs are required for suppression of TH17 cells
during B. fragilis colonization.
PSA is an immunomodulatory bacterial mol-
ecule that shapes host immune responses (17).
Induction of IL-10 and interferon-g (IFN-g) from
CD4+ T cells by PSA requires TLR2 signaling
(14, 18). We sought to determine the mechanism
whereby B. fragilis suppresses TH17 cell responses
by testing whether PSA functions through TLR2
signaling by dendritic cells (DCs) and/or CD4+
T cells. PSA elicited a significant increase in IL-10
and IFN-g production from mixed cultures of
wild-type DCs and wild-type CD4+ T cells in
vitro (Fig. 2A and fig. S5). When Tlr2−/− T cells
were cocultured with wild-type DCs, however,
PSA-induced IL-10 production was reduced, where-
as IFN-g expression was not affected (Fig. 2A
and fig. S5), which indicated that PSA required
TLR2 expression on T cells to promote IL-10
production. IL-10 responses to PSA were spe-
cific to T cells (fig. S6). Consistent with previous
findings (18), proinflammatory IFN-g produc-
tion was dependent on TLR2 signaling by DCs
(fig. S5); however, IL-10 production was unaf-
fected in cultures containing wild-type CD4+ T
cells and Tlr2−/− DCs (Fig. 2A). Therefore, TLR2
expression by T lymphocytes is necessary for
IL-10 production by PSA.
CD4+ Tcells produce IL-10 in response to PSA
in the absence of antigen-presenting cells (APCs)
(Fig. 2B). Moreover, PSA induces IL-10 expres-
sion from purified T cells in a dose-dependent
manner, whereas other TLR2 ligands do not
(fig. S7). TLR2 can function as either a homo-
dimer or a heterodimer with TLR1 or TLR6 (19).
PSA could induce high amounts of IL-10 from
wild-type, Tlr1−/−, and Tlr6−/− CD4+ T cells;
however, IL-10 production was lost only from
Tlr2−/− CD4+ T cells and T cells deleted in the
TLR adapter molecule MyD88 (Fig. 2B). To
determine Treg suppression as a function of cell-
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Fig. 1. PSA actively suppresses TH17 cell development during
B. fragilis colonization through Foxp3+ Tregs. (A) Colonic lam-
ina propria lymphocytes (LPLs) were harvested and stained
with antibodies against CD4 and IL-17A and analyzed by flow
cytometry. Numbers indicate the percentage of CD4+IL-17A+
(TH17) cells. Conventional mice are specific pathogen free.
(B) Compiled data from three independent experiments as in
(A). CV, conventional; GF, germ-free; B.frag, B. fragilis; DPSA,
B. fragilisDPSA. ***P < 0.001, two-way analysis of variance.
(C and D) CD4+ T cells were isolated from the mesenteric
lymph nodes of the indicated animals. RNA was collected and
used as a template to determine the relative levels of IL-17A
(C) and RORgt (D) transcript. Error bars represent SDs from
triplicate samples. The data are representative of three in-
dependent experiments. (E) B. fragilisDPSA mono-associated
mice were treated with either phosphate-buffered saline (PBS)
or PSA, and the LPLs were isolated and the percentage of CD4+
IL-17A–producing cells was determined by flow cytometry.
Each symbol represents an individual animal (n = 3 to 4 mice
per group). ***P < 0.001. (F and G) Germ-free Rag1−/− ani-
mals were reconstituted with bone marrow from Foxp3-DTR
mice and then mono-associated with B. fragilis. Animals were
treated with either PBS (−DT) or diphtheria toxin (+DT) as de-
scribed (16). Colonic LPLs were harvested after Treg ablation and
restimulated with phorbol 12-myristate 13-acetate (PMA)–
ionomycin and brefeldin A. Cells were stained with antibodies to CD4, Foxp3, and IL-17A and analyzed by flow cytometry. (Right) Symbols represent T cell
proportions from individual mice within a single experiment (n = 3 to 4 mice per group) and are representative of two independent trials. ***P < 0.001.
Fig. 2. PSA signals through TLR2 on CD4+ T cells
to suppress TH17 cell responses. (A) Bone
marrow–derived dendritic cells from wild-type
(WT) or Tlr2−/− mice were incubated with splenic
CD4+ T cells. Amounts of secreted IL-10 were
determined by enzyme-linked immunosorbent
assay (ELISA). Error bars represent SDs from two
independent assays performed in quadruplicate.
***P < 0.001; NS, not significant. (B) CD4+ T cells
were isolated from WT mice, and the indicated
knockout mice and cells were stimulated as in (A).
MyD is Myd88−/−. IL-10 was assayed by ELISA.
**P < 0.01. Error bars represent SDs for quadrupli-
cate samples and are representative of two inde-
pendent trials. (C) CD4+Foxp3+ Tregs were purified
from Foxp3EGFP mice (26) and Tlr2−/− X Foxp3EGFP
mice and stimulated with plate-bound antibodies
against CD3 and recombinant TGF-b, with PSA or
with the indicated TLR ligands. Equal numbers of
live cultured Tregs were then incubated with CFSE
(carboxyfluorescein diacetate succinimidyl ester)–
pulsed responder cells (CD4+Foxp3–). Percent
suppression is determined by the ratio of pro-
liferating responder cells in each condition rel-
ative to proliferation in the absence of added
Tregs. Error bars are SDs from a single exper-
iment performed in duplicate and are repre-
sentative of two independent trials. (D and E)
Germ-free Rag1−/− animals were reconstituted
with CD4+ T cells from WT or Tlr2−/− mice and
then mono-associated with either WT B. fragilis
or B. fragilisDPSA. Colonic LPLs were isolated and
analyzed for TH17 cell proportions by flow cytom-
etry. Plots are gated on CD4+ cells. (D) Each
symbol represents an individual animal (n = 3 to
4 mice per group), and data are representative of
two independent trials. **P < 0.01; ***P < 0.001.
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intrinsic TLR2 signaling, we measured prolifer-
ation of responder T cells after coculture with
Tregs stimulated in vitro with PSA, or classical
TLR2 ligands Pam3CysK or Pam2CysK. The
proportion of Foxp3+ T cells was equivalent under
all conditions (fig. S8). PSA-treated Tregs displayed
increased suppressive capacity compared to me-
dia or other TLR2 ligand–treated Tregs (Fig. 2C).
IL-2 was not produced by Tregs during treatment
with any of the TLR2 ligands, and IL-2 neutral-
ization had no effect on in vitro suppression (fig.
S9). Notably, the suppressive capacity of PSA-
treated Tregs was lost when Foxp3
+ T cells were
deficient in TLR2 (Fig. 2C). PSA likely directed
the development of inducible Tregs by promot-
ing the expression of IL-10, transforming growth
factor–b2 (TGF-b2), and Foxp3 from purified
Foxp3+ T cells in a TLR2-dependent fashion (fig.
S10). Collectively, these studies show that unlike
other TLR2 ligands, PSA enhances Treg function
and gene expression in the absence of APCs
through TLR2 signaling directly on CD4+Foxp3+
Treg cells.
We next determined whether PSA signals
through TLR2 on Foxp3+ Tregs during B. fragilis
colonization of animals to suppress TH17 cell re-
sponses. Germ-free Rag1−/− mice were reconsti-
tuted with purified CD4+ T cells from wild-type
or Tlr2−/− animals. Animals were subsequent-
ly mono-associated with either B. fragilis or
B. fragilisDPSA. Unlike wild-type animals,
IL-10–producing Foxp3+ Tregs were not induced
in the gut of B. fragilis mono-colonized ani-
mals that were reconstituted with Tlr2−/− CD4+ T
cells (fig. S11). Although we observed minimal
TH17 cell development in wild-type mice mono-
associated with B. fragilis, TH17 cell responses
were significantly increased during colonization
of animals that were reconstituted with Tlr2−/−
CD4+ T cells (Fig. 2, D and E). Furthermore,
TLR2-deficient CD4+ T cells from B. fragilis
mono-associated mice produced more IL-17A
compared to mice reconstituted with wild-type
CD4+ T cells (fig. S12). Collectively, these data
demonstrate that B. fragilis requires TLR2 to
induce Foxp3+ Tregs during intestinal colonization
and actively suppresses TH17 responses through
engagement of TLR2 specifically on T cells.
The intestinal microbiota occupies both mu-
cosal and luminal niches during normal coloni-
zation; however, the biogeographic distributions
of specific microbial species are poorly charac-
terized. We reasoned that the functions of PSA
were driven by an evolutionary impetus to pre-
vent deleterious mucosal immune reactions to
B. fragilis, enabling bacteria to associate with
host tissue. Intriguingly, we discovered a popu-
lation of bacteria that intimately associates with
the intestinal epithelium (Fig. 3A). Whole-mount
preparations of medial colons were probed for
bacteria after labeling with B. fragilis–specific
antisera (fig. S13). Three-dimensional reconstruc-
tion of confocal microscopic images revealed
microcolonies of B. fragilis residing within co-
lonic crypts (Fig. 3A). The amounts of B. fragilis
associated with host tissue represented a fraction
of total bacteria (Fig. 3, B and C), but likely are
an important population that are in close prox-
imity to the host immune system. We speculated
that the amounts of tissue-associated bacteria would
be sensitive to host immune responses such as TH17
cell induction. Notably, animals colonized with
B. fragilisDPSA displayed profoundly reduced num-
bers of tissue-associated bacteria when compared
to animals colonized with wild-type B. fragilis
(Fig. 3D). Treatment of B. fragilisDPSA–colonized
animals with purified PSA corrected this defect
and increased colonization of B. fragilisDPSA
to wild-type bacterial levels (Fig. 3D). Only tissue-
associated bacteria were affected, because no
differences were observed in the amounts of bac-
teria in the gut lumen by either strain (fig. S14)
(17). Collectively, these data identify a previously
unappreciated mucosal niche for B. fragilis and
reveal that PSA is required for maintaining host-
bacterial symbiosis at the epithelial surface of
the gut.
Fig. 3. Mucosal colonization of B. fragilis
requires suppression of host TH17 re-
sponses. (A) Colons from germ-free or
B. fragilis mono-associated mice were
fixed, stained with chicken antibodies
against B. fragilis (green) and nuclear-
counterstained with 4´,6-diamidino-2-
phenylindole (DAPI) (white) and imaged
by whole-mount confocal microscopy. Im-
ages are similar to five different z-stack
images per colon and representative of five mice. (B) Colon sections or luminal
contents from B. fragilis mono-associated mice were homogenized and serially
diluted to obtain live bacterial counts. CFUs (colony-forming units) per gram of
tissue were determined after microbiologic plating. Each symbol represents an
individual animal (n = 3 to 4 animals per group) and is representative of
three independent trials. ***P < 0.001. (C) Quantitative reverse transcription–
polymerase chain reaction (qRT-PCR) analysis was performed withBacteriodes-
specific primers on RNA extracted from colon tissue or luminal contents. GF,
germ-free; BF, B. fragilis. Error bars represent SDs from individual mice in the
same experiment and are representative of two independent trials. (D) qRT-
PCR analysis for B. fragilis was performed on RNA extracted from colon
homogenates from indicated animals. The bar furthest to the right shows
colonization of B. fragilisDPSA in animals orally treated with purified PSA.
GF, germ-free; B.frag, B. fragilis; DPSA, B. fragilisDPSA. Data are shown for
four animals per group and are representative of two independent trials. **P <
0.01. (E) Germ-free Rag1−/− animals were reconstituted with Tlr2−/− or WT CD4+
T cells and colonized with either WT B. fragilis or B. fragilisDPSA. Colons were
prepared and analyzed as in (D). **P < 0.01. (F) Germ-free Rag1−/− animals
were reconstituted with Foxp3-DTR bone marrow and colonized with B. fragilis.
Two months after reconstitution animals were treated with either PBS (−DT) or
with diphtheria toxin (+DT), and colons were prepared as described in (D). **P <
0.01. (G and H) Neutralization of IL-17A increases B. fragilis colonization. Germ-
free animals were colonized with B. fragilisDPSA and treated with either an
antibody that neutralizes IL-17A (a-IL-17A) or an isotype control (Iso). Colon
homogenates were analyzed by live bacterial plating (G) or qRT-PCR (H) as
described in (B) and (C). Each symbol in (G) represents an individual animal.
Error bars in (H) show the SDs from individual animals and are compiled data
from two independent trials with three or four animals per group. *P < 0.05.
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Our findings suggest that PSA induces Tregs
through TLR2 signaling to suppress TH17 cell re-
sponses and promote mucosal colonization by
B. fragilis. To test this model, we measured colo-
nization levels of B. fragilis in Rag1−/− mice
reconstituted with TLR2-deficient CD4+ T cells.
Tissue association by wild-type B. fragilis in the
colon was reduced to the levels ofB. fragilisDPSA
in these mice (Fig. 3E and fig. S15). Moreover,
Foxp3+ Treg ablation in B. fragilismono-associated
animals resulted in significantly reduced amounts
of tissue-associated B. fragilis (Fig. 3F), with-
out affecting bacterial numbers in the lumen of
the gut (fig. S16). Finally, to functionally determine
the role of IL-17 responses in mucosal associa-
tion, we treated B. fragilisDPSA mono-associated
animals with a neutralizing antibody to IL-17A.
Whereas the amounts of B. fragilisDPSA in isotype
control–treated animals remained low, neutraliza-
tion of IL-17A resulted in a 1000-fold increase
in tissue-associated bacteria (Fig. 3, G and H).
These data indicate that IL-17 suppression by PSA
is required by B. fragilis during association with its
host. Therefore, unlike pathogens that trigger in-
flammatory responses through TLRs to clear in-
fections, symbiotic colonization by B. fragilis is
actually enhanced via the TLR pathway. We con-
clude that PSA evolved to engender host-bacterial
mutualism by inducing mucosal tolerance through
TLR2 activation of Treg cells.
The gastrointestinal tract represents a pri-
mary portal for entry by numerous pathogens.
Toll-like receptors recognize MAMPs (microbial-
associated molecular patterns) expressed by bacte-
ria and coordinate a cascade of innate and adaptive
immune responses that control infections (20).
Although TLRs have classically been studied on
innate immune cells, recent reports have dem-
onstrated their expression by T cells in both
mice and humans (4, 21–23). As bacteria contain
universally conserved MAMPs, how do commen-
sal microbes, unlike pathogens, avoid triggering
TLR activation? It is historically believed that
the microbiota is excluded from the mucosal
surface (24). However, certain symbiotic bacte-
ria tightly adhere to the intestinal mucosa (9–11),
and thus immunologic ignorance may not ex-
plain why inflammation is averted by the mi-
crobiota. Our study provides new insight into
the mechanisms by which the immune system
distinguishes between pathogens and symbionts.
The functional activity of PSA on Tregs contrasts
with the role of TLR2 ligands of pathogens,
which elicit inflammation, and thus reveals an
unexpected function for TLR signaling during
homeostatic intestinal colonization by the micro-
biota. Although engagement of TLR2 by pre-
viously identified ligands is known to stimulate
microbial clearance of pathogens, TLR signal-
ing by PSA paradoxically allows B. fragilis per-
sistence on mucosal surfaces. These results identify
PSA as the incipient member of a new class of
TLR ligands termed “symbiont-associated mo-
lecular patterns (SAMPs)” that function to orches-
trate immune responses to establish host-commensal
symbiosis. On the basis of the importance of the
microbiota to mammalian health (25), evolution
appears to have created molecular interactions that
engender host-bacterial mutualism. In conclusion,
our findings suggest that animals are not “hard-
wired” to intrinsically distinguish pathogens from
symbionts, and that microbial-derived mecha-
nisms have evolved to actively promote immuno-
logic tolerance to symbiotic bacteria. This concept
suggests a reconsideration of how we define self
versus nonself.
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A Packing Mechanism for Nucleosome
Organization Reconstituted Across a
Eukaryotic Genome
Zhenhai Zhang,1* Christian J. Wippo,2* Megha Wal,1 Elissa Ward,1
Philipp Korber,2† B. Franklin Pugh1†
Near the 5′ end of most eukaryotic genes, nucleosomes form highly regular arrays that begin
at canonical distances from the transcriptional start site. Determinants of this and other aspects
of genomic nucleosome organization have been ascribed to statistical positioning, intrinsically
DNA-encoded positioning, or some aspect of transcription initiation. Here, we provide evidence
for a different explanation. Biochemical reconstitution of proper nucleosome positioning, spacing,
and occupancy levels was achieved across the 5′ ends of most yeast genes by adenosine
triphosphate–dependent trans-acting factors. These transcription-independent activities override
DNA-intrinsic positioning and maintain uniform spacing at the 5′ ends of genes even at
low nucleosome densities. Thus, an active, nonstatistical nucleosome packing mechanism
creates chromatin organizing centers at the 5′ ends of genes where important regulatory
elements reside.
Statistical positioning depends on the pres-ence of a genomic barrier within a lineararray of nucleosomes (1). Nucleosomes
within the array will passively align at regular
intervals from the barrier, independent of sequence
or other external factors, rather than arrange
randomly. Nucleosome organization in vivo dis-
plays patterns that are consistent with statistical
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